| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | kinase activity | SMG1 GNE PIK3R3 FN3KRP HUNK STK31 BCR CERT1 MAP3K1 TTBK1 MAPK12 PPP1R9B AKT1 AKT2 FGFR1 FGFR3 FGFR2 MARK2 WNK3 NEK11 | 1.19e-06 | 764 | 150 | 20 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | SMG1 GNE PIK3R3 FN3KRP HUNK STK31 BCR MAP3K1 TTBK1 MAPK12 PPP1R9B AKT1 AKT2 FGFR1 FGFR3 FGFR2 MARK2 WNK3 NEK11 | 1.60e-06 | 709 | 150 | 19 | GO:0016773 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | SMG1 GNE PIK3R3 FN3KRP HUNK STK31 BCR CERT1 MAP3K1 PARP6 TTBK1 MAPK12 PPP1R9B AKT1 AKT2 FGFR1 FGFR3 FGFR2 MARK2 TNKS2 WNK3 NEK11 | 2.04e-06 | 938 | 150 | 22 | GO:0016772 |
| GeneOntologyMolecularFunction | fibroblast growth factor receptor activity | 4.11e-06 | 5 | 150 | 3 | GO:0005007 | |
| GeneOntologyMolecularFunction | protein kinase activity | SMG1 HUNK STK31 BCR MAP3K1 TTBK1 MAPK12 PPP1R9B AKT1 AKT2 FGFR1 FGFR3 FGFR2 MARK2 WNK3 NEK11 | 1.20e-05 | 600 | 150 | 16 | GO:0004672 |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 1.35e-05 | 20 | 150 | 4 | GO:0046624 | |
| GeneOntologyMolecularFunction | steroid hormone binding | 1.42e-05 | 7 | 150 | 3 | GO:1990239 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | SMG1 HUNK STK31 BCR MAP3K1 TTBK1 MAPK12 AKT1 AKT2 MARK2 WNK3 NEK11 | 1.98e-05 | 363 | 150 | 12 | GO:0106310 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC1 KIF6 SMC6 ATP10B MORC4 NLRP3 ABCB1 SHOC1 ATP1A1 ATP1A2 ATP1A3 HSPA1L DYNC1H1 | 2.94e-05 | 441 | 150 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 4.80e-05 | 10 | 150 | 3 | GO:0008554 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 4.80e-05 | 10 | 150 | 3 | GO:0005391 | |
| GeneOntologyMolecularFunction | tRNA-4-demethylwyosine synthase activity | 5.61e-05 | 2 | 150 | 2 | GO:0102521 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC1 KIF6 MYH9 MYO7A SMC6 ATP10B MORC4 NLRP3 ABCB1 SHOC1 ATP1A1 ATP1A2 ATP1A3 HSPA1L DYNC1H1 | 6.19e-05 | 614 | 150 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 6.56e-05 | 11 | 150 | 3 | GO:0008556 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | EEFSEC ABCC1 KIF6 GBP7 SMC6 ATP10B MORC4 NLRP3 ABCB1 SHOC1 ATP1A1 ATP1A2 ATP1A3 HSPA1L AGAP4 AGAP6 DYNC1H1 | 7.48e-05 | 775 | 150 | 17 | GO:0017111 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | SMG1 HUNK STK31 BCR MAP3K1 TTBK1 MAPK12 AKT1 AKT2 MARK2 WNK3 NEK11 | 1.42e-04 | 446 | 150 | 12 | GO:0004674 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | EEFSEC ABCC1 KIF6 GBP7 SMC6 ATP10B MORC4 NLRP3 ABCB1 SHOC1 ATP1A1 ATP1A2 ATP1A3 HSPA1L AGAP4 AGAP6 DYNC1H1 | 1.94e-04 | 839 | 150 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | EEFSEC ABCC1 KIF6 GBP7 SMC6 ATP10B MORC4 NLRP3 ABCB1 SHOC1 ATP1A1 ATP1A2 ATP1A3 HSPA1L AGAP4 AGAP6 DYNC1H1 | 1.97e-04 | 840 | 150 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | EEFSEC ABCC1 KIF6 GBP7 SMC6 ATP10B MORC4 NLRP3 ABCB1 SHOC1 ATP1A1 ATP1A2 ATP1A3 HSPA1L AGAP4 AGAP6 DYNC1H1 | 1.97e-04 | 840 | 150 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 2.38e-04 | 74 | 150 | 5 | GO:0005548 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 2.62e-04 | 17 | 150 | 3 | GO:0042813 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 2.66e-04 | 279 | 150 | 9 | GO:0005096 | |
| GeneOntologyMolecularFunction | group III metabotropic glutamate receptor activity | 3.33e-04 | 4 | 150 | 2 | GO:0001642 | |
| GeneOntologyMolecularFunction | lipid binding | ACADL PARD3B CERT1 BDH1 NLRP3 MAP3K1 FZD7 TIAM1 SNX25 RACGAP1 AKT1 EEA1 MARK2 ATP1A1 ATP1A2 ATP1A3 AGAP4 AGAP6 | 4.52e-04 | 988 | 150 | 18 | GO:0008289 |
| GeneOntologyMolecularFunction | ADP binding | 4.60e-04 | 48 | 150 | 4 | GO:0043531 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 5.81e-04 | 51 | 150 | 4 | GO:0140303 | |
| GeneOntologyMolecularFunction | phospholipid binding | PARD3B CERT1 BDH1 NLRP3 FZD7 TIAM1 SNX25 RACGAP1 AKT1 EEA1 AGAP4 AGAP6 | 9.03e-04 | 548 | 150 | 12 | GO:0005543 |
| GeneOntologyMolecularFunction | kinase binding | TRIM49 MYH9 ANGPT1 TRIM49C TRIM68 MAP3K1 RYR2 PARP6 TIAM1 PKD1 RACGAP1 PRKAR1B PPP1R9B AKT1 AKT2 ATP1A1 TRIM49B | 9.95e-04 | 969 | 150 | 17 | GO:0019900 |
| GeneOntologyMolecularFunction | fibroblast growth factor binding | 1.06e-03 | 27 | 150 | 3 | GO:0017134 | |
| GeneOntologyMolecularFunction | oxo-acid-lyase activity | 1.15e-03 | 7 | 150 | 2 | GO:0016833 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.40e-03 | 109 | 150 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF6 VPS18 MYH9 CLXN CENPF MYO7A SYNE1 MAP3K1 TTBK1 CYFIP1 DST TIAM1 FAM161A RACGAP1 TLN2 PPP1R9B MARK2 ATP1A1 | 1.53e-03 | 1099 | 150 | 18 | GO:0008092 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK2 RANGAP1 PSD3 BCR DOCK5 ASAP2 TIAM1 SRGAP3 RACGAP1 AGAP4 AGAP6 | 1.59e-03 | 507 | 150 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK2 RANGAP1 PSD3 BCR DOCK5 ASAP2 TIAM1 SRGAP3 RACGAP1 AGAP4 AGAP6 | 1.59e-03 | 507 | 150 | 11 | GO:0030695 |
| GeneOntologyMolecularFunction | protein dimerization activity | ANO2 MYH9 GBP7 CENPF SYNE1 SREBF2 ANO5 TSG101 TRIM68 PPP3CA DST GRHPR AKT1 FGFR1 FGFR2 EEA1 ATP1A1 ATP1A2 FZD2 | 1.75e-03 | 1205 | 150 | 19 | GO:0046983 |
| GeneOntologyMolecularFunction | calmodulin binding | 1.80e-03 | 230 | 150 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.87e-03 | 171 | 150 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 1.95e-03 | 9 | 150 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 1.95e-03 | 9 | 150 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | protein kinase binding | TRIM49 MYH9 ANGPT1 TRIM49C TRIM68 MAP3K1 RYR2 TIAM1 PKD1 RACGAP1 PRKAR1B AKT1 AKT2 ATP1A1 TRIM49B | 2.42e-03 | 873 | 150 | 15 | GO:0019901 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 2.47e-03 | 36 | 150 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 2.47e-03 | 36 | 150 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | LRRC8E ANO2 CNNM2 GJC1 ANO5 RYR2 CNNM4 CACNA2D4 NALCN PKD1 SCNN1B ATP1A1 ATP1A2 ATP1A3 | 2.64e-03 | 793 | 150 | 14 | GO:0015075 |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 2.72e-03 | 316 | 150 | 8 | GO:0035091 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CNNM2 RYR2 CNNM4 CACNA2D4 NALCN PKD1 SCNN1B ATP1A1 ATP1A2 ATP1A3 | 2.75e-03 | 465 | 150 | 10 | GO:0046873 |
| GeneOntologyMolecularFunction | lipid transporter activity | 3.69e-03 | 196 | 150 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | enzyme activator activity | DOCK2 RANGAP1 BCR NLRP3 DOCK5 PARP6 ASAP2 SRGAP3 RACGAP1 MARK2 AGAP4 AGAP6 | 4.00e-03 | 656 | 150 | 12 | GO:0008047 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ABCC1 ANO2 CNNM2 ANO5 RYR2 CNNM4 CACNA2D4 NALCN PKD1 SCNN1B ATP1A1 ATP1A2 ATP1A3 | 4.76e-03 | 758 | 150 | 13 | GO:0015318 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 4.80e-03 | 145 | 150 | 5 | GO:0004713 | |
| GeneOntologyMolecularFunction | potassium ion binding | 4.81e-03 | 14 | 150 | 2 | GO:0030955 | |
| GeneOntologyMolecularFunction | sodium ion binding | 4.81e-03 | 14 | 150 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 4.81e-03 | 14 | 150 | 2 | GO:0140333 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling involved in cardiac conduction | 1.07e-06 | 26 | 149 | 5 | GO:0086064 | |
| GeneOntologyBiologicalProcess | response to glycoside | 3.66e-06 | 5 | 149 | 3 | GO:1903416 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling | 5.01e-06 | 35 | 149 | 5 | GO:0010644 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | LRRC8E ABCC1 PPP3CA SCNN1B AKT1 AKT2 ATP1A1 ATP1A2 ATP1A3 WNK3 | 6.91e-06 | 230 | 149 | 10 | GO:0098739 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | RANGAP1 BCR NLRP3 ASAP2 TTBK1 MAPK12 TIAM1 AKT1 AKT2 FGFR1 FGFR3 FGFR2 AGAP4 AGAP6 | 1.62e-05 | 499 | 149 | 14 | GO:0051345 |
| GeneOntologyBiologicalProcess | regulation of phospholipase activity | 1.73e-05 | 22 | 149 | 4 | GO:0010517 | |
| GeneOntologyBiologicalProcess | osmosensory signaling pathway | 2.01e-05 | 8 | 149 | 3 | GO:0007231 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development | 5.18e-05 | 2 | 149 | 2 | GO:0035607 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid transport | 5.84e-05 | 11 | 149 | 3 | GO:2000192 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of transmembrane electrochemical gradient | 5.84e-05 | 11 | 149 | 3 | GO:0010248 | |
| GeneOntologyBiologicalProcess | intracellular sodium ion homeostasis | 6.19e-05 | 30 | 149 | 4 | GO:0006883 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 6.73e-05 | 59 | 149 | 5 | GO:0086065 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | RANGAP1 VPS18 ZNF366 PIK3R3 REN TRIM68 SERPINA12 CYFIP1 PPP3CA SCNN1B AKT1 AKT2 ATP1A1 ATP1A2 ATP1A3 DNAJA1 | 7.54e-05 | 727 | 149 | 16 | GO:0032870 |
| GeneOntologyBiologicalProcess | long-chain fatty acid import across plasma membrane | 7.75e-05 | 12 | 149 | 3 | GO:0015911 | |
| GeneOntologyBiologicalProcess | regulation of sodium ion transport | 9.26e-05 | 101 | 149 | 6 | GO:0002028 | |
| GeneOntologyBiologicalProcess | import into cell | LRRC8E DOCK2 ABCC1 MYH9 ANGPT1 MYO7A SYNE1 TSG101 ITGA4 BCR PLA2R1 PPP3CA SCNN1B AKT1 AKT2 EEA1 ATP1A1 ATP1A2 ATP1A3 WNK3 | 9.47e-05 | 1074 | 149 | 20 | GO:0098657 |
| GeneOntologyBiologicalProcess | cellular response to lipid | VPS18 GBP7 ZNF366 TRIM68 BCR NLRP3 FZD7 CCDC62 SCNN1B PPP1R9B AKT1 FGFR2 ATP1A1 ATP1A2 ATP1A3 DNAJA1 | 1.05e-04 | 748 | 149 | 16 | GO:0071396 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.25e-04 | 153 | 149 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | positive regulation of phospholipase activity | 1.27e-04 | 14 | 149 | 3 | GO:0010518 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | LRRC8E ABCC1 ANO2 CNNM2 GJC1 ANO5 RYR2 ABCB1 CNNM4 CACNA2D4 PPP3CA NALCN DHRS7C PKD1 SCNN1B RACGAP1 AKT1 FTL AKT2 ATP1A1 ATP1A2 ATP1A3 WNK3 | 1.36e-04 | 1374 | 149 | 23 | GO:0006811 |
| GeneOntologyBiologicalProcess | activation of GTPase activity | 1.41e-04 | 109 | 149 | 6 | GO:0090630 | |
| GeneOntologyBiologicalProcess | potassium ion homeostasis | 1.43e-04 | 37 | 149 | 4 | GO:0055075 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor receptor apoptotic signaling pathway | 1.55e-04 | 3 | 149 | 2 | GO:1902178 | |
| GeneOntologyBiologicalProcess | ventricular zone neuroblast division | 1.55e-04 | 3 | 149 | 2 | GO:0021847 | |
| GeneOntologyBiologicalProcess | orbitofrontal cortex development | 1.55e-04 | 3 | 149 | 2 | GO:0021769 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | LRRC8E ABCC1 ANO2 CNNM2 GJC1 ANO5 RYR2 ABCB1 CNNM4 CACNA2D4 PPP3CA NALCN DHRS7C PKD1 SCNN1B AKT1 ATP1A1 ATP1A2 ATP1A3 WNK3 | 1.57e-04 | 1115 | 149 | 20 | GO:0034220 |
| GeneOntologyBiologicalProcess | organelle localization | VPS18 MYH9 CENPF MYO7A SYNE1 VPS33A PARD3B TSG101 ITGA4 CEP120 PKD1 RACGAP1 FGFR2 MARK2 DYNC1H1 | 1.79e-04 | 703 | 149 | 15 | GO:0051640 |
| GeneOntologyBiologicalProcess | sodium ion transport | 1.79e-04 | 275 | 149 | 9 | GO:0006814 | |
| GeneOntologyBiologicalProcess | response to hormone | RANGAP1 VPS18 ZNF366 PIK3R3 SREBF2 GATM REN TRIM68 SERPINA12 CYFIP1 PPP3CA SCNN1B PPP1R9B AKT1 AKT2 ATP1A1 ATP1A2 ATP1A3 DNAJA1 | 1.88e-04 | 1042 | 149 | 19 | GO:0009725 |
| GeneOntologyBiologicalProcess | regulation of lipase activity | 2.15e-04 | 41 | 149 | 4 | GO:0060191 | |
| GeneOntologyBiologicalProcess | intracellular potassium ion homeostasis | 2.33e-04 | 17 | 149 | 3 | GO:0030007 | |
| GeneOntologyBiologicalProcess | sodium ion export across plasma membrane | 2.33e-04 | 17 | 149 | 3 | GO:0036376 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | RANGAP1 ANGPT1 TRIM68 BCR NLRP3 MAP3K1 RYR2 ABCB1 ASAP2 TTBK1 PPP3CA MAPK12 TIAM1 AKT1 AKT2 FGFR1 FGFR3 FGFR2 MARK2 FZD2 AGAP4 AGAP6 WNK3 | 2.43e-04 | 1430 | 149 | 23 | GO:0044093 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation | TRIM49 RANGAP1 VPS18 ANGPT1 SMC6 TRIM49C TRIM49D1 TSG101 TRIM68 MAGEF1 MAP3K1 DAW1 AKT1 FGFR3 TNKS2 DNAJA1 TRIM49B | 2.54e-04 | 893 | 149 | 17 | GO:0032446 |
| GeneOntologyBiologicalProcess | post-translational protein modification | TRIM49 RANGAP1 VPS18 ANGPT1 FN3KRP SMC6 TRIM49C TRIM49D1 TSG101 TRIM68 MAGEF1 MAP3K1 PARP6 DAW1 AKT1 FGFR3 TNKS2 DNAJA1 TRIM49B | 2.76e-04 | 1074 | 149 | 19 | GO:0043687 |
| GeneOntologyBiologicalProcess | vasculogenesis involved in coronary vascular morphogenesis | 2.78e-04 | 18 | 149 | 3 | GO:0060979 | |
| GeneOntologyBiologicalProcess | circulatory system process | ABCC1 MYL1 ANGPT1 GJC1 REN ITGA4 BCR RYR2 ABCB1 DOCK5 SCNN1B AKT1 ATP1A1 ATP1A2 ATP1A3 | 2.80e-04 | 733 | 149 | 15 | GO:0003013 |
| GeneOntologyBiologicalProcess | regulation of system process | SYNE1 SREBF2 GJC1 REN ITGA4 RYR2 DOCK5 PPP3CA PRKAR1B AKT1 FGFR1 ATP1A1 ATP1A2 ATP1A3 WNK3 | 2.84e-04 | 734 | 149 | 15 | GO:0044057 |
| GeneOntologyBiologicalProcess | negative regulation of long-chain fatty acid import across plasma membrane | 3.08e-04 | 4 | 149 | 2 | GO:0010748 | |
| GeneOntologyBiologicalProcess | negative regulation of long-chain fatty acid import into cell | 3.08e-04 | 4 | 149 | 2 | GO:0140213 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 3.54e-04 | 239 | 149 | 8 | GO:0071383 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid import into cell | 3.85e-04 | 20 | 149 | 3 | GO:0044539 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | VPS18 ZNF366 TRIM68 RYR2 CCDC62 SCNN1B PPP1R9B AKT1 AKT2 ATP1A1 ATP1A2 ATP1A3 DNAJA1 | 4.58e-04 | 605 | 149 | 13 | GO:0071407 |
| GeneOntologyBiologicalProcess | potassium ion import across plasma membrane | 5.02e-04 | 51 | 149 | 4 | GO:1990573 | |
| GeneOntologyBiologicalProcess | sodium ion homeostasis | 5.02e-04 | 51 | 149 | 4 | GO:0055078 | |
| GeneOntologyBiologicalProcess | sphingolipid translocation | 5.11e-04 | 5 | 149 | 2 | GO:0099039 | |
| GeneOntologyBiologicalProcess | fatty acid transmembrane transport | 5.14e-04 | 22 | 149 | 3 | GO:1902001 | |
| GeneOntologyBiologicalProcess | export across plasma membrane | 5.19e-04 | 91 | 149 | 5 | GO:0140115 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 5.87e-04 | 142 | 149 | 6 | GO:0098659 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 5.87e-04 | 142 | 149 | 6 | GO:0099587 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | MYH9 CENPF MYO7A SYNE1 PARD3B TSG101 ITGA4 CEP120 PKD1 RACGAP1 FGFR2 DYNC1H1 | 6.23e-04 | 546 | 149 | 12 | GO:0051656 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | RANGAP1 BCR SERPINA12 NLRP3 PLA2R1 ASAP2 TTBK1 MAPK12 TIAM1 AKT1 AKT2 FGFR1 FGFR3 FGFR2 AGAP4 AGAP6 | 6.26e-04 | 878 | 149 | 16 | GO:0051336 |
| GeneOntologyBiologicalProcess | muscle system process | MYL1 GJC1 GATM CERT1 RYR2 DOCK5 PPP3CA TIAM1 SCNN1B ATP1A1 ATP1A2 ATP1A3 | 6.33e-04 | 547 | 149 | 12 | GO:0003012 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | SMG1 MYH9 MNS1 CENPF SYNE1 PPFIA1 SMC6 SREBF2 TSG101 MAP3K1 CYFIP1 CEP120 PKD1 NFRKB AKT1 FGFR1 FGFR3 FGFR2 MARK2 TNKS2 DYNC1H1 | 6.63e-04 | 1342 | 149 | 21 | GO:0033043 |
| GeneOntologyBiologicalProcess | chemical homeostasis | MYH9 CNNM2 VPS33A SREBF2 IREB2 CERT1 RYR2 CNNM4 PPP3CA TIAM1 DHRS7C SCNN1B AKT1 FTL FGFR1 FGFR3 ATP1A1 ATP1A2 ATP1A3 WNK3 | 6.76e-04 | 1249 | 149 | 20 | GO:0048878 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | CNNM2 VPS33A IREB2 RYR2 CNNM4 DHRS7C SCNN1B FTL FGFR1 FGFR3 ATP1A1 ATP1A2 ATP1A3 WNK3 | 7.12e-04 | 717 | 149 | 14 | GO:0050801 |
| GeneOntologyBiologicalProcess | negative regulation of lipid transport | 7.18e-04 | 56 | 149 | 4 | GO:0032369 | |
| GeneOntologyBiologicalProcess | positive regulation of lipase activity | 7.56e-04 | 25 | 149 | 3 | GO:0060193 | |
| GeneOntologyBiologicalProcess | maturation of LSU-rRNA | 7.56e-04 | 25 | 149 | 3 | GO:0000470 | |
| GeneOntologyBiologicalProcess | lipid import into cell | 7.56e-04 | 25 | 149 | 3 | GO:0140354 | |
| GeneOntologyBiologicalProcess | wybutosine metabolic process | 7.63e-04 | 6 | 149 | 2 | GO:0031590 | |
| GeneOntologyBiologicalProcess | wybutosine biosynthetic process | 7.63e-04 | 6 | 149 | 2 | GO:0031591 | |
| GeneOntologyBiologicalProcess | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway | 7.63e-04 | 6 | 149 | 2 | GO:0090080 | |
| GeneOntologyBiologicalProcess | xenobiotic transport across blood-brain barrier | 7.63e-04 | 6 | 149 | 2 | GO:1990962 | |
| GeneOntologyBiologicalProcess | forebrain ventricular zone progenitor cell division | 7.63e-04 | 6 | 149 | 2 | GO:0021869 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | LRRC8E ACADL SYNE1 IREB2 GRM8 NLRP3 RYR2 ABCB1 CACNA2D4 CYFIP1 TIPIN PKD1 SCNN1B AKT1 AKT2 FGFR2 ATP1A1 ATP1A2 ATP1A3 DNAJA1 WNK3 | 7.94e-04 | 1361 | 149 | 21 | GO:0009628 |
| GeneOntologyBiologicalProcess | cardiac conduction | 7.98e-04 | 100 | 149 | 5 | GO:0061337 | |
| GeneOntologyBiologicalProcess | protein ubiquitination | TRIM49 VPS18 ANGPT1 TRIM49C TRIM49D1 TSG101 TRIM68 MAGEF1 MAP3K1 DAW1 AKT1 FGFR3 TNKS2 DNAJA1 TRIM49B | 8.00e-04 | 811 | 149 | 15 | GO:0016567 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 8.04e-04 | 208 | 149 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | blood circulation | MYL1 ANGPT1 GJC1 REN ITGA4 BCR RYR2 DOCK5 SCNN1B AKT1 ATP1A1 ATP1A2 ATP1A3 | 8.65e-04 | 648 | 149 | 13 | GO:0008015 |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 8.74e-04 | 59 | 149 | 4 | GO:0007215 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 9.08e-04 | 344 | 149 | 9 | GO:0003018 | |
| GeneOntologyBiologicalProcess | positive regulation of endocytosis | 9.23e-04 | 213 | 149 | 7 | GO:0045807 | |
| GeneOntologyBiologicalProcess | Rac protein signal transduction | 9.32e-04 | 60 | 149 | 4 | GO:0016601 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | TRIM49 RANGAP1 VPS18 ANGPT1 SMC6 TRIM49C TRIM49D1 TSG101 TRIM68 MAGEF1 MAP3K1 DAW1 AKT1 FGFR3 TNKS2 DNAJA1 TRIM49B | 1.01e-03 | 1009 | 149 | 17 | GO:0070647 |
| GeneOntologyBiologicalProcess | biological process involved in symbiotic interaction | 1.05e-03 | 351 | 149 | 9 | GO:0044403 | |
| GeneOntologyBiologicalProcess | regulation of long-chain fatty acid import across plasma membrane | 1.06e-03 | 7 | 149 | 2 | GO:0010746 | |
| GeneOntologyBiologicalProcess | forebrain neuroblast division | 1.06e-03 | 7 | 149 | 2 | GO:0021873 | |
| GeneOntologyCellularComponent | postsynapse | SYNE1 PPFIA1 PSD3 BCR HNRNPH1 HNRNPH2 RPL10A CYFIP1 PPP3CA DST TIAM1 SRGAP3 PRKAR1B PPP1R9B AKT1 FGFR1 RPS10P5 EEA1 MARK2 ATP1A1 ATP1A2 ATP1A3 | 3.29e-06 | 1018 | 149 | 22 | GO:0098794 |
| GeneOntologyCellularComponent | anchoring junction | MYH9 PPFIA1 GJC1 PARD3B ITGA4 ABCB1 RPL10A DOCK5 CYFIP1 PPP3CA DST TIAM1 TLN2 PPP1R9B AKT1 FGFR3 ATP1A1 ATP1A2 FZD2 WNK3 PDZD2 | 6.02e-06 | 976 | 149 | 21 | GO:0070161 |
| GeneOntologyCellularComponent | neuron spine | SYNE1 PPFIA1 BCR CYFIP1 PPP3CA TIAM1 PPP1R9B EEA1 ATP1A2 ATP1A3 | 1.15e-05 | 247 | 149 | 10 | GO:0044309 |
| GeneOntologyCellularComponent | cell-cell junction | MYH9 GJC1 PARD3B ITGA4 ABCB1 PPP3CA DST TIAM1 TLN2 PPP1R9B AKT1 ATP1A1 ATP1A2 WNK3 PDZD2 | 2.20e-05 | 591 | 149 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | cell-cell contact zone | 5.76e-05 | 94 | 149 | 6 | GO:0044291 | |
| GeneOntologyCellularComponent | dendritic spine | 6.15e-05 | 242 | 149 | 9 | GO:0043197 | |
| GeneOntologyCellularComponent | sodium:potassium-exchanging ATPase complex | 7.45e-05 | 12 | 149 | 3 | GO:0005890 | |
| GeneOntologyCellularComponent | intercalated disc | 1.25e-04 | 68 | 149 | 5 | GO:0014704 | |
| GeneOntologyCellularComponent | dendritic spine head | 1.86e-04 | 16 | 149 | 3 | GO:0044327 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 2.50e-04 | 230 | 149 | 8 | GO:0098562 | |
| GeneOntologyCellularComponent | photoreceptor inner segment membrane | 3.00e-04 | 4 | 149 | 2 | GO:0060342 | |
| GeneOntologyCellularComponent | cell cortex | 3.38e-04 | 371 | 149 | 10 | GO:0005938 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 3.70e-04 | 185 | 149 | 7 | GO:0009898 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | PSD3 GRM4 BCR HNRNPH1 HNRNPH2 RPL10A DST TIAM1 PRKAR1B PPP1R9B ATP1A1 ATP1A3 | 3.78e-04 | 523 | 149 | 12 | GO:0098984 |
| GeneOntologyCellularComponent | somatodendritic compartment | RANGAP1 SYNE1 PPFIA1 SREBF2 IREB2 ITGA4 GRM4 BCR GRM8 ADCY9 CNNM4 TTBK1 CYFIP1 PPP3CA TIAM1 PPP1R9B MARK2 ATP1A2 ATP1A3 DYNC1H1 | 4.62e-04 | 1228 | 149 | 20 | GO:0036477 |
| GeneOntologyCellularComponent | lateral plasma membrane | 4.65e-04 | 90 | 149 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | transporter complex | LRRC8E ANO2 ATP10B RYR2 CACNA2D4 OLFM3 NALCN PKD1 SCNN1B ATP1A1 ATP1A2 ATP1A3 | 5.91e-04 | 550 | 149 | 12 | GO:1990351 |
| GeneOntologyCellularComponent | ruffle | 7.02e-04 | 206 | 149 | 7 | GO:0001726 | |
| GeneOntologyCellularComponent | glutamatergic synapse | ANO2 VPS18 CNNM2 PSD3 GRM4 BCR GRM8 PPP3CA TIAM1 SRGAP3 PRKAR1B AKT1 FGFR1 EEA1 MARK2 | 7.53e-04 | 817 | 149 | 15 | GO:0098978 |
| GeneOntologyCellularComponent | CORVET complex | 1.04e-03 | 7 | 149 | 2 | GO:0033263 | |
| GeneOntologyCellularComponent | dendrite | RANGAP1 SYNE1 PPFIA1 SREBF2 GRM4 BCR ADCY9 CNNM4 CYFIP1 PPP3CA TIAM1 PPP1R9B MARK2 ATP1A2 ATP1A3 | 1.23e-03 | 858 | 149 | 15 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | RANGAP1 SYNE1 PPFIA1 SREBF2 GRM4 BCR ADCY9 CNNM4 CYFIP1 PPP3CA TIAM1 PPP1R9B MARK2 ATP1A2 ATP1A3 | 1.26e-03 | 860 | 149 | 15 | GO:0097447 |
| GeneOntologyCellularComponent | transmembrane transporter complex | LRRC8E ANO2 RYR2 CACNA2D4 OLFM3 NALCN PKD1 SCNN1B ATP1A1 ATP1A2 ATP1A3 | 1.34e-03 | 523 | 149 | 11 | GO:1902495 |
| GeneOntologyCellularComponent | dendritic spine neck | 1.76e-03 | 9 | 149 | 2 | GO:0044326 | |
| GeneOntologyCellularComponent | axon | RANGAP1 PPFIA1 IREB2 ITGA4 GRM4 BCR ADCY9 CYFIP1 DST TIAM1 PPP1R9B EEA1 ATP1A1 ATP1A3 DYNC1H1 | 1.78e-03 | 891 | 149 | 15 | GO:0030424 |
| GeneOntologyCellularComponent | cilium | ANO2 CLXN MNS1 CENPF MYO7A CFAP210 TIAM1 FAM161A DAW1 PKD1 PRKAR1B AKT1 ATP1A1 CFAP44 PMFBP1 | 1.92e-03 | 898 | 149 | 15 | GO:0005929 |
| GeneOntologyCellularComponent | asymmetric synapse | PSD3 GRM4 BCR HNRNPH1 HNRNPH2 RPL10A DST TIAM1 PPP1R9B ATP1A1 | 2.26e-03 | 477 | 149 | 10 | GO:0032279 |
| GeneOntologyCellularComponent | photoreceptor inner segment | 2.35e-03 | 78 | 149 | 4 | GO:0001917 | |
| GeneOntologyCellularComponent | sarcolemma | 2.44e-03 | 190 | 149 | 6 | GO:0042383 | |
| MousePheno | abnormal cranial synchondrosis | 1.15e-05 | 6 | 118 | 3 | MP:0030443 | |
| MousePheno | abnormal cranial cartilage development | 4.75e-05 | 9 | 118 | 3 | MP:0030467 | |
| MousePheno | abnormal eye distance/ position | 5.75e-05 | 80 | 118 | 6 | MP:0001299 | |
| MousePheno | premature bone ossification | 6.25e-05 | 26 | 118 | 4 | MP:0003416 | |
| MousePheno | premature facial suture closure | 7.07e-05 | 2 | 118 | 2 | MP:0030390 | |
| MousePheno | premature sphenooccipital synchondrosis closure | 7.07e-05 | 2 | 118 | 2 | MP:0030446 | |
| MousePheno | ocular hypertelorism | 9.73e-05 | 29 | 118 | 4 | MP:0001300 | |
| Domain | FGF_rcpt_fam | 1.90e-06 | 4 | 147 | 3 | IPR016248 | |
| Domain | Kinase-like_dom | SMG1 FN3KRP HUNK STK31 MAP3K1 TTBK1 DST MAPK12 AKT1 AKT2 FGFR1 FGFR3 FGFR2 MARK2 WNK3 NEK11 | 5.94e-06 | 542 | 147 | 16 | IPR011009 |
| Domain | P-type_ATPase_IIC | 9.39e-06 | 6 | 147 | 3 | IPR005775 | |
| Domain | tRNA_wybutosine-synth | 6.15e-05 | 2 | 147 | 2 | IPR013917 | |
| Domain | Wyosine_form | 6.15e-05 | 2 | 147 | 2 | PF08608 | |
| Domain | SPRY | 6.42e-05 | 87 | 147 | 6 | SM00449 | |
| Domain | PROTEIN_KINASE_ATP | HUNK STK31 MAP3K1 TTBK1 MAPK12 AKT1 AKT2 FGFR1 FGFR3 FGFR2 MARK2 WNK3 NEK11 | 7.06e-05 | 459 | 147 | 13 | PS00107 |
| Domain | SPRY | 9.89e-05 | 94 | 147 | 6 | PF00622 | |
| Domain | SPRY_dom | 9.89e-05 | 94 | 147 | 6 | IPR003877 | |
| Domain | B30.2/SPRY | 1.05e-04 | 95 | 147 | 6 | IPR001870 | |
| Domain | B302_SPRY | 1.05e-04 | 95 | 147 | 6 | PS50188 | |
| Domain | - | 1.12e-04 | 32 | 147 | 4 | 3.40.1110.10 | |
| Domain | - | 1.12e-04 | 32 | 147 | 4 | 2.70.150.10 | |
| Domain | Prot_kinase_dom | HUNK STK31 MAP3K1 TTBK1 MAPK12 AKT1 AKT2 FGFR1 FGFR3 FGFR2 MARK2 WNK3 NEK11 | 1.33e-04 | 489 | 147 | 13 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | HUNK STK31 MAP3K1 TTBK1 MAPK12 AKT1 AKT2 FGFR1 FGFR3 FGFR2 MARK2 WNK3 NEK11 | 1.44e-04 | 493 | 147 | 13 | PS50011 |
| Domain | ATPase_P-typ_cyto_domN | 1.60e-04 | 35 | 147 | 4 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 1.78e-04 | 36 | 147 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 1.78e-04 | 36 | 147 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.78e-04 | 36 | 147 | 4 | PS00154 | |
| Domain | Znf_CHHC | 1.84e-04 | 3 | 147 | 2 | IPR012996 | |
| Domain | zf-RNPHF | 1.84e-04 | 3 | 147 | 2 | PF08080 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.99e-04 | 37 | 147 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.99e-04 | 37 | 147 | 4 | PF00122 | |
| Domain | BBOX | 2.11e-04 | 69 | 147 | 5 | SM00336 | |
| Domain | Butyrophylin | 2.26e-04 | 70 | 147 | 5 | IPR003879 | |
| Domain | - | 2.42e-04 | 71 | 147 | 5 | 4.10.45.10 | |
| Domain | ATPase_P-typ_TM_dom | 2.48e-04 | 16 | 147 | 3 | IPR023298 | |
| Domain | - | 2.48e-04 | 16 | 147 | 3 | 1.20.1110.10 | |
| Domain | zf-B_box | 2.58e-04 | 72 | 147 | 5 | PF00643 | |
| Domain | - | 2.74e-04 | 391 | 147 | 11 | 2.30.29.30 | |
| Domain | ATPase_P-typ_cation-transptr_C | 3.00e-04 | 17 | 147 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 3.00e-04 | 17 | 147 | 3 | PF00689 | |
| Domain | Cation_ATPase_N | 3.57e-04 | 18 | 147 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 3.57e-04 | 18 | 147 | 3 | SM00831 | |
| Domain | PH | 3.62e-04 | 278 | 147 | 9 | SM00233 | |
| Domain | DUF21 | 3.65e-04 | 4 | 147 | 2 | IPR002550 | |
| Domain | DUF21 | 3.65e-04 | 4 | 147 | 2 | PF01595 | |
| Domain | PH_DOMAIN | 3.72e-04 | 279 | 147 | 9 | PS50003 | |
| Domain | PH_domain | 3.82e-04 | 280 | 147 | 9 | IPR001849 | |
| Domain | HAD-like_dom | 3.98e-04 | 79 | 147 | 5 | IPR023214 | |
| Domain | ATPase_P-typ_cation-transptr_N | 4.22e-04 | 19 | 147 | 3 | IPR004014 | |
| Domain | ZF_BBOX | 4.22e-04 | 80 | 147 | 5 | PS50119 | |
| Domain | Znf_B-box | 4.47e-04 | 81 | 147 | 5 | IPR000315 | |
| Domain | PH | 4.67e-04 | 229 | 147 | 8 | PF00169 | |
| Domain | Ser/Thr_kinase_AS | 5.38e-04 | 357 | 147 | 10 | IPR008271 | |
| Domain | S_TKc | 5.62e-04 | 359 | 147 | 10 | SM00220 | |
| Domain | PH_dom-like | 5.63e-04 | 426 | 147 | 11 | IPR011993 | |
| Domain | PROTEIN_KINASE_ST | 5.99e-04 | 362 | 147 | 10 | PS00108 | |
| Domain | DOCK_N | 6.06e-04 | 5 | 147 | 2 | PF16172 | |
| Domain | DOCK_N | 6.06e-04 | 5 | 147 | 2 | IPR032376 | |
| Domain | YIPPEE | 6.06e-04 | 5 | 147 | 2 | PS51792 | |
| Domain | Protein_kinase_ATP_BS | 8.51e-04 | 379 | 147 | 10 | IPR017441 | |
| Domain | Pkinase | 8.86e-04 | 381 | 147 | 10 | PF00069 | |
| Domain | Anoct_dimer | 1.26e-03 | 7 | 147 | 2 | PF16178 | |
| Domain | Anoct_dimer | 1.26e-03 | 7 | 147 | 2 | IPR032394 | |
| Domain | ArfGap | 1.50e-03 | 29 | 147 | 3 | SM00105 | |
| Domain | ARFGAP | 1.50e-03 | 29 | 147 | 3 | PS50115 | |
| Domain | ArfGap | 1.50e-03 | 29 | 147 | 3 | PF01412 | |
| Domain | ArfGAP | 1.50e-03 | 29 | 147 | 3 | IPR001164 | |
| Domain | Yippee/Mis18/Cereblon | 1.67e-03 | 8 | 147 | 2 | IPR004910 | |
| Domain | Flavodoxin/NO_synth | 1.67e-03 | 8 | 147 | 2 | IPR008254 | |
| Domain | Yippee-Mis18 | 1.67e-03 | 8 | 147 | 2 | PF03226 | |
| Domain | Flavdoxin-like | 1.67e-03 | 8 | 147 | 2 | IPR001094 | |
| Domain | GPCR_3_mtglu_rcpt | 1.67e-03 | 8 | 147 | 2 | IPR000162 | |
| Domain | FLAVODOXIN_LIKE | 1.67e-03 | 8 | 147 | 2 | PS50902 | |
| Domain | Flavodoxin_1 | 1.67e-03 | 8 | 147 | 2 | PF00258 | |
| Domain | rSAM | 2.14e-03 | 9 | 147 | 2 | IPR007197 | |
| Domain | Radical_SAM | 2.14e-03 | 9 | 147 | 2 | PF04055 | |
| Domain | Prefoldin | 2.50e-03 | 72 | 147 | 4 | IPR009053 | |
| Domain | Anoctamin | 2.66e-03 | 10 | 147 | 2 | PF04547 | |
| Domain | Anoctamin | 2.66e-03 | 10 | 147 | 2 | IPR007632 | |
| Domain | - | 2.66e-03 | 10 | 147 | 2 | 3.40.50.360 | |
| Domain | Flavoprotein-like_dom | 2.66e-03 | 10 | 147 | 2 | IPR029039 | |
| Domain | Frizzled | 3.23e-03 | 11 | 147 | 2 | IPR000539 | |
| Domain | Frizzled | 3.23e-03 | 11 | 147 | 2 | PF01534 | |
| Domain | DHR-1_domain | 3.23e-03 | 11 | 147 | 2 | IPR027007 | |
| Domain | DHR_2 | 3.23e-03 | 11 | 147 | 2 | PS51651 | |
| Domain | DHR_1 | 3.23e-03 | 11 | 147 | 2 | PS51650 | |
| Domain | DHR-2 | 3.23e-03 | 11 | 147 | 2 | PF06920 | |
| Domain | DOCK | 3.23e-03 | 11 | 147 | 2 | IPR026791 | |
| Domain | DOCK_C | 3.23e-03 | 11 | 147 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 3.23e-03 | 11 | 147 | 2 | PF14429 | |
| Domain | DHR-2 | 3.23e-03 | 11 | 147 | 2 | IPR027357 | |
| Domain | Frizzled | 3.23e-03 | 11 | 147 | 2 | SM01330 | |
| Domain | NCD3G | 4.53e-03 | 13 | 147 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 4.53e-03 | 13 | 147 | 2 | IPR011500 | |
| Domain | GPCR_3_CS | 5.26e-03 | 14 | 147 | 2 | IPR017979 | |
| Domain | - | 6.38e-03 | 48 | 147 | 3 | 2.60.120.10 | |
| Domain | Frizzled/SFRP | 6.87e-03 | 16 | 147 | 2 | IPR015526 | |
| Domain | SH3 | 7.32e-03 | 216 | 147 | 6 | PS50002 | |
| Domain | RmlC-like_jellyroll | 7.55e-03 | 51 | 147 | 3 | IPR014710 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 7.74e-03 | 17 | 147 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 7.74e-03 | 17 | 147 | 2 | PS51059 | |
| Domain | PARP | 7.74e-03 | 17 | 147 | 2 | PF00644 | |
| Domain | - | 7.74e-03 | 17 | 147 | 2 | 3.90.228.10 | |
| Domain | Peptidase_aspartic_dom | 7.74e-03 | 17 | 147 | 2 | IPR021109 | |
| Domain | ConA-like_dom | 7.81e-03 | 219 | 147 | 6 | IPR013320 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 3.42e-07 | 9 | 104 | 4 | M47397 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | ANO2 ANO5 ATP10B RYR2 NALCN SCNN1B ATP1A1 ATP1A2 ATP1A3 WNK3 | 9.66e-07 | 183 | 104 | 10 | M997 |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 2.20e-06 | 116 | 104 | 8 | MM15863 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 2.35e-06 | 117 | 104 | 8 | M39530 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY | 2.54e-06 | 83 | 104 | 7 | M47961 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY | 2.89e-06 | 31 | 104 | 5 | M47396 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY | 4.07e-06 | 89 | 104 | 7 | M47963 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 5.97e-06 | 176 | 104 | 9 | MM15718 | |
| Pathway | WP_ENDOMETRIAL_CANCER | 6.74e-06 | 63 | 104 | 6 | M39623 | |
| Pathway | REACTOME_INFECTIOUS_DISEASE | DOCK2 ANO2 RANGAP1 VPS18 MYH9 VPS33A ANO5 TSG101 ITGA4 ADCY9 NLRP3 RPL10A FZD7 PARP6 CYFIP1 PRKAR1B AKT1 AKT2 ATP1A1 ATP1A2 ATP1A3 DYNC1H1 | 1.03e-05 | 1081 | 104 | 22 | M27548 |
| Pathway | WP_MAPK_SIGNALING | MAP3K1 CACNA2D4 PPP3CA MAPK12 AKT1 AKT2 FGFR1 FGFR3 FGFR2 HSPA1L | 1.35e-05 | 246 | 104 | 10 | M39597 |
| Pathway | KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION | 1.36e-05 | 42 | 104 | 5 | M16473 | |
| Pathway | WP_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR | 2.22e-05 | 23 | 104 | 4 | MM15952 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | LRRC8E ABCC1 ANO2 IREB2 ANO5 ATP10B ADCY9 RYR2 ABCB1 NALCN SCNN1B PRKAR1B FTL ATP1A1 ATP1A2 ATP1A3 WNK3 | 2.54e-05 | 736 | 104 | 17 | M27287 |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 2.62e-05 | 118 | 104 | 7 | M39852 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | MAP3K1 CACNA2D4 PPP3CA MAPK12 AKT1 AKT2 FGFR1 FGFR3 FGFR2 HSPA1L | 2.74e-05 | 267 | 104 | 10 | M10792 |
| Pathway | WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION | 3.14e-05 | 25 | 104 | 4 | M39384 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY | 3.17e-05 | 9 | 104 | 3 | M47972 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 3.23e-05 | 50 | 104 | 5 | M48087 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 4.63e-05 | 88 | 104 | 6 | M41810 | |
| Pathway | WP_EBOLA_VIRUS_INFECTION_IN_HOST | 4.64e-05 | 129 | 104 | 7 | M39693 | |
| Pathway | WP_CARDIAC_HYPERTROPHIC_RESPONSE | 5.15e-05 | 55 | 104 | 5 | M39685 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 6.41e-05 | 184 | 104 | 8 | M41809 | |
| Pathway | WP_RAS_SIGNALING | 6.41e-05 | 184 | 104 | 8 | M39764 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 8.97e-05 | 99 | 104 | 6 | MM15905 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 1.18e-04 | 104 | 104 | 6 | M39625 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.31e-04 | 106 | 104 | 6 | M27200 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | LRRC8E ABCC1 ANO2 IREB2 ANO5 ATP10B RYR2 ABCB1 NALCN SCNN1B PRKAR1B FTL ATP1A1 ATP1A2 ATP1A3 | 1.36e-04 | 681 | 104 | 15 | MM14985 |
| Pathway | REACTOME_PI3K_AKT_SIGNALING_IN_CANCER | 1.61e-04 | 110 | 104 | 6 | M27162 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY | 1.66e-04 | 15 | 104 | 3 | M47971 | |
| Pathway | PID_RAC1_REG_PATHWAY | 1.70e-04 | 38 | 104 | 4 | M241 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 1.77e-04 | 213 | 104 | 8 | M18306 | |
| Pathway | REACTOME_SARS_COV_INFECTIONS | ANO2 VPS18 VPS33A ANO5 ITGA4 NLRP3 PARP6 AKT1 AKT2 ATP1A1 ATP1A2 ATP1A3 | 1.79e-04 | 471 | 104 | 12 | M39009 |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.87e-04 | 161 | 104 | 7 | M39770 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT | 2.08e-04 | 40 | 104 | 4 | M39798 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 2.13e-04 | 74 | 104 | 5 | M39857 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 2.36e-04 | 118 | 104 | 6 | M713 | |
| Pathway | KEGG_VEGF_SIGNALING_PATHWAY | 2.42e-04 | 76 | 104 | 5 | M1749 | |
| Pathway | REACTOME_VIRAL_INFECTION_PATHWAYS | DOCK2 ANO2 RANGAP1 VPS18 VPS33A ANO5 TSG101 ITGA4 NLRP3 RPL10A PARP6 AKT1 AKT2 ATP1A1 ATP1A2 ATP1A3 DYNC1H1 | 2.54e-04 | 888 | 104 | 17 | M48034 |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER | 2.77e-04 | 43 | 104 | 4 | M39788 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 2.90e-04 | 79 | 104 | 5 | M17673 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 3.11e-04 | 175 | 104 | 7 | MM15599 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 3.60e-04 | 46 | 104 | 4 | M8626 | |
| Pathway | KEGG_ENDOCYTOSIS | 3.82e-04 | 181 | 104 | 7 | M1519 | |
| Pathway | WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE | 3.86e-04 | 84 | 104 | 5 | M39839 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | ANGPT1 ITGA4 NLRP3 MAP3K1 FZD7 AKT1 AKT2 FGFR1 FGFR3 FGFR2 FZD2 | 3.89e-04 | 439 | 104 | 11 | M42563 |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 4.08e-04 | 85 | 104 | 5 | M3578 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 4.24e-04 | 48 | 104 | 4 | M26916 | |
| Pathway | WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY | 4.31e-04 | 132 | 104 | 6 | M39338 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 4.54e-04 | 87 | 104 | 5 | MM15600 | |
| Pathway | KEGG_APOPTOSIS | 4.54e-04 | 87 | 104 | 5 | M8492 | |
| Pathway | KEGG_PROSTATE_CANCER | 5.04e-04 | 89 | 104 | 5 | M13191 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 5.06e-04 | 313 | 104 | 9 | M27867 | |
| Pathway | BIOCARTA_MRP_PATHWAY | 5.31e-04 | 5 | 104 | 2 | MM1586 | |
| Pathway | KEGG_MEDICUS_VARIANT_CDX2_OVEREXPRESSION_TO_TRANSCRIPTIONAL_ACTIVATION | 5.31e-04 | 5 | 104 | 2 | M48976 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY | 5.31e-04 | 5 | 104 | 2 | M48999 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 5.42e-04 | 22 | 104 | 3 | M13897 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 5.48e-04 | 252 | 104 | 8 | MM15585 | |
| Pathway | KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION | 6.20e-04 | 23 | 104 | 3 | M4361 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 6.20e-04 | 23 | 104 | 3 | MM1424 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 6.20e-04 | 23 | 104 | 3 | M7897 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 6.20e-04 | 23 | 104 | 3 | MM14993 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 6.63e-04 | 325 | 104 | 9 | M12868 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 6.66e-04 | 54 | 104 | 4 | M27168 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 6.66e-04 | 54 | 104 | 4 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 6.66e-04 | 54 | 104 | 4 | MM15202 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 6.66e-04 | 54 | 104 | 4 | M620 | |
| Pathway | WP_ANGIOGENESIS | 7.05e-04 | 24 | 104 | 3 | M39556 | |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 7.13e-04 | 96 | 104 | 5 | M16121 | |
| Pathway | PID_FGF_PATHWAY | 7.14e-04 | 55 | 104 | 4 | M276 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 7.14e-04 | 55 | 104 | 4 | M971 | |
| Pathway | BIOCARTA_MRP_PATHWAY | 7.93e-04 | 6 | 104 | 2 | M22078 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY | 7.93e-04 | 6 | 104 | 2 | M47523 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 7.97e-04 | 25 | 104 | 3 | MM1441 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 7.97e-04 | 25 | 104 | 3 | M47934 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DOCK2 RANGAP1 MYH9 CENPF PIK3R3 BCR DOCK5 CYFIP1 DST TIAM1 SRGAP3 FAM169A RACGAP1 DYNC1H1 | 8.07e-04 | 720 | 104 | 14 | M41838 |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 8.18e-04 | 57 | 104 | 4 | MM15643 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 8.19e-04 | 99 | 104 | 5 | MM14910 | |
| Pathway | WP_PI3KAKT_SIGNALING | 8.94e-04 | 339 | 104 | 9 | M39736 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 8.96e-04 | 26 | 104 | 3 | M17941 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DOCK2 RANGAP1 MYH9 CENPF PIK3R3 BCR DOCK5 CYFIP1 DST SRGAP3 FAM169A RACGAP1 DYNC1H1 | 9.56e-04 | 649 | 104 | 13 | MM15690 |
| Pathway | WP_BREAST_CANCER_PATHWAY | 9.70e-04 | 154 | 104 | 6 | M39739 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY | 1.11e-03 | 7 | 104 | 2 | M47407 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY | 1.11e-03 | 7 | 104 | 2 | M47790 | |
| Pathway | BIOCARTA_NO1_PATHWAY | 1.12e-03 | 28 | 104 | 3 | M4383 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR_IN_DISEASE | 1.19e-03 | 63 | 104 | 4 | M635 | |
| Pathway | KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY | 1.21e-03 | 108 | 104 | 5 | M9904 | |
| Pathway | WP_LIPID_METABOLISM_PATHWAY | 1.24e-03 | 29 | 104 | 3 | M39762 | |
| Pathway | WP_CHEMOKINE_SIGNALING | 1.38e-03 | 165 | 104 | 6 | M39400 | |
| Pathway | WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS | 1.42e-03 | 66 | 104 | 4 | M39642 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY | 1.47e-03 | 8 | 104 | 2 | M47399 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 1.47e-03 | 8 | 104 | 2 | M47394 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 1.47e-03 | 8 | 104 | 2 | M47395 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY | 1.47e-03 | 8 | 104 | 2 | M47404 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 1.47e-03 | 8 | 104 | 2 | M47405 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY | 1.47e-03 | 8 | 104 | 2 | M47803 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 1.47e-03 | 8 | 104 | 2 | M47715 | |
| Pathway | REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION | 1.47e-03 | 8 | 104 | 2 | M27806 | |
| Pathway | KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.47e-03 | 8 | 104 | 2 | M47482 | |
| Pathway | WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION | 1.47e-03 | 8 | 104 | 2 | M48325 | |
| Pubmed | SMG1 RANGAP1 MYH9 CENPF SYNE1 PPFIA1 ATP10B CFAP210 TEX35 STK31 UBLCP1 RYR2 ABCB1 DST NSA2 FAM161A SNX25 FAM169A PPP1R9B FGFR1 EEA1 ATP1A1 ATP1A2 ATP1A3 DNAJA1 HSPA1L FBXO15 | 1.89e-10 | 1442 | 153 | 27 | 35575683 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | SYNE1 PPFIA1 ASAP2 CYFIP1 PPP3CA SRGAP3 TLN2 PPP1R9B AGAP4 AGAP6 DYNC1H1 | 5.33e-08 | 281 | 153 | 11 | 28706196 |
| Pubmed | ZBTB20 is essential for cochlear maturation and hearing in mice. | 6.08e-08 | 47 | 153 | 6 | 37279265 | |
| Pubmed | VPS18 MYH9 ACADL MYO7A SYNE1 PPFIA1 PSD3 TSG101 BCR HNRNPH1 RPL10A CYFIP1 PPP3CA DST SRGAP3 TLN2 PPP1R9B RPS10P5 MARK2 ATP1A1 ATP1A2 ATP1A3 DYNC1H1 | 8.07e-08 | 1431 | 153 | 23 | 37142655 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 8382556 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 23185502 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 19728793 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 20301628 | ||
| Pubmed | Na+/K+-ATPase α isoform deficiency results in distinct spreading depolarization phenotypes. | 8.35e-08 | 3 | 153 | 3 | 30819023 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 7896824 | ||
| Pubmed | Enriched Environment Promotes Adult Hippocampal Neurogenesis through FGFRs. | 8.35e-08 | 3 | 153 | 3 | 33637561 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 19058785 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 18216705 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 8203495 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 25994790 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 31189094 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 2822726 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 30755670 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 17947306 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 28465228 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 18044013 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 33433858 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 9286594 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 29097598 | ||
| Pubmed | Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancer. | 8.35e-08 | 3 | 153 | 3 | 24898159 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 31830366 | ||
| Pubmed | FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer. | 8.35e-08 | 3 | 153 | 3 | 24850843 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 26911348 | ||
| Pubmed | Loss of Dlg-1 in the mouse lens impairs fibroblast growth factor receptor signaling. | 1.16e-07 | 11 | 153 | 4 | 24824078 | |
| Pubmed | 1.16e-07 | 11 | 153 | 4 | 26906157 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | PPFIA1 PSD3 GJC1 PARD3B ITGA4 ADCY9 CNNM4 CYFIP1 DST TIAM1 MARK2 ATP1A1 | 1.24e-07 | 377 | 153 | 12 | 38117590 |
| Pubmed | Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer. | 1.40e-07 | 28 | 153 | 5 | 24462114 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.47e-07 | 197 | 153 | 9 | 20811636 | |
| Pubmed | RANGAP1 MYH9 CENPF SYNE1 PPFIA1 GRM4 BCR CYFIP1 PPP3CA DST SRGAP3 RACGAP1 PRKAR1B TLN2 PPP1R9B DNAJA1 DYNC1H1 WNK3 | 2.73e-07 | 963 | 153 | 18 | 28671696 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 21849490 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 10704861 | ||
| Pubmed | Astrocyte activation is suppressed in both normal and injured brain by FGF signaling. | 3.33e-07 | 4 | 153 | 3 | 25002516 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 20360004 | ||
| Pubmed | FGFR1-4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer. | 3.33e-07 | 4 | 153 | 3 | 36142417 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 9664689 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 19751721 | ||
| Pubmed | Agrin regulation of alpha3 sodium-potassium ATPase activity modulates cardiac myocyte contraction. | 3.33e-07 | 4 | 153 | 3 | 19376779 | |
| Pubmed | The FGF system has a key role in regulating vascular integrity. | 3.33e-07 | 4 | 153 | 3 | 18776942 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 17234593 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 21731499 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 12458206 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 17414280 | ||
| Pubmed | Isolated sagittal and coronal craniosynostosis associated with TWIST box mutations. | 3.33e-07 | 4 | 153 | 3 | 17343269 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 9212826 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 11759058 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 32858001 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 12644244 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 17446412 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 27154171 | ||
| Pubmed | Immunolocalization of fibroblast growth factor receptors in normal and wounded human skin. | 3.33e-07 | 4 | 153 | 3 | 12373339 | |
| Pubmed | RNAi-based conditional gene knockdown in mice using a U6 promoter driven vector. | 3.33e-07 | 4 | 153 | 3 | 17304337 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | SMG1 RANGAP1 MYH9 CENPF VPS33A GATM TSG101 HNRNPH2 RPL10A CYFIP1 DST SRGAP3 TLN2 | 3.53e-07 | 498 | 153 | 13 | 36634849 |
| Pubmed | 4.38e-07 | 65 | 153 | 6 | 34645483 | ||
| Pubmed | 4.73e-07 | 15 | 153 | 4 | 28465335 | ||
| Pubmed | 6.29e-07 | 16 | 153 | 4 | 24145799 | ||
| Pubmed | RANGAP1 MYH9 ACADL VPS33A PSD3 TSG101 BCR BDH1 HNRNPH2 RYR2 SRGAP3 SNX25 FAM169A PRKAR1B TLN2 PPP1R9B AKT2 ATP1A2 DNAJA1 | 6.95e-07 | 1139 | 153 | 19 | 36417873 | |
| Pubmed | 7.52e-07 | 225 | 153 | 9 | 12168954 | ||
| Pubmed | 8.20e-07 | 17 | 153 | 4 | 36230906 | ||
| Pubmed | FGF-Dependent, Context-Driven Role for FRS Adapters in the Early Telencephalon. | 8.20e-07 | 17 | 153 | 4 | 28483978 | |
| Pubmed | Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference. | 8.29e-07 | 5 | 153 | 3 | 15987787 | |
| Pubmed | Multiple genes encode the human Na+,K+-ATPase catalytic subunit. | 8.29e-07 | 5 | 153 | 3 | 3035563 | |
| Pubmed | FGF21 signalling pathway and metabolic traits - genetic association analysis. | 8.29e-07 | 5 | 153 | 3 | 20717167 | |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 19696444 | ||
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 27206683 | ||
| Pubmed | Nectin-1 binds and signals through the fibroblast growth factor receptor. | 8.29e-07 | 5 | 153 | 3 | 22955284 | |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 9300656 | ||
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 9013630 | ||
| Pubmed | The mouse Fgfrl1 gene coding for a novel FGF receptor-like protein. | 8.29e-07 | 5 | 153 | 3 | 11566361 | |
| Pubmed | The expression profiles of fibroblast growth factor 9 and its receptors in developing mice testes. | 8.29e-07 | 5 | 153 | 3 | 27078042 | |
| Pubmed | Different intracellular trafficking of FGF1 endocytosed by the four homologous FGF receptors. | 8.29e-07 | 5 | 153 | 3 | 16091423 | |
| Pubmed | FGF-dependent regulation of VEGF receptor 2 expression in mice. | 8.29e-07 | 5 | 153 | 3 | 21633168 | |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 26855332 | ||
| Pubmed | Expression of fibroblast growth factor receptors in peri-implantation mouse embryos. | 8.29e-07 | 5 | 153 | 3 | 9771645 | |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 28094278 | ||
| Pubmed | Expression and biological activity of mouse fibroblast growth factor-9. | 8.29e-07 | 5 | 153 | 3 | 8576175 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RANGAP1 MYH9 MYL1 SYNE1 HNRNPH1 WDR43 RPL10A ZNHIT6 DST NSA2 RACGAP1 PPP1R9B MARK2 ATP1A1 DNAJA1 KLHDC4 DYNC1H1 | 1.07e-06 | 949 | 153 | 17 | 36574265 |
| Pubmed | Identification of a genomic reservoir for new TRIM genes in primate genomes. | 1.33e-06 | 19 | 153 | 4 | 22144910 | |
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 10572038 | ||
| Pubmed | Evidence that the novel receptor FGFRL1 signals indirectly via FGFR1. | 1.65e-06 | 6 | 153 | 3 | 24026051 | |
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 16365308 | ||
| Pubmed | Regulation of fibroblast growth factor-23 signaling by klotho. | 1.65e-06 | 6 | 153 | 3 | 16436388 | |
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 19232523 | ||
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 20448149 | ||
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 38056728 | ||
| Pubmed | Transport and pharmacological properties of nine different human Na, K-ATPase isozymes. | 1.65e-06 | 6 | 153 | 3 | 10636900 | |
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 3036582 | ||
| Pubmed | The complex morphology of reactive astrocytes controlled by fibroblast growth factor signaling. | 1.65e-06 | 6 | 153 | 3 | 24796693 | |
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 9010207 | ||
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 29720668 | ||
| Pubmed | Gyrification of the cerebral cortex requires FGF signaling in the mammalian brain. | 1.65e-06 | 6 | 153 | 3 | 29132503 | |
| Pubmed | SMC6 SREBF2 PSD3 FZD7 DST SRGAP3 FAM161A SCG2 PKD1 FAM169A RACGAP1 FTL FGFR1 FGFR3 FGFR2 TNKS2 FZD2 | 2.35e-06 | 1006 | 153 | 17 | 15226823 | |
| Pubmed | ABCC1 PPFIA1 PIK3R3 PSD3 PARD3B ITGA4 ADCY9 CYFIP1 DST MARK2 ATP1A1 | 2.88e-06 | 421 | 153 | 11 | 36976175 | |
| Pubmed | 2.88e-06 | 7 | 153 | 3 | 19261608 | ||
| Pubmed | 2.88e-06 | 7 | 153 | 3 | 16772167 | ||
| Pubmed | 2.88e-06 | 7 | 153 | 3 | 8959336 | ||
| Interaction | ATP1A2 interactions | 9.86e-07 | 45 | 150 | 6 | int:ATP1A2 | |
| Interaction | TBC1D31 interactions | 3.67e-06 | 56 | 150 | 6 | int:TBC1D31 | |
| Interaction | SNCA interactions | SMG1 RANGAP1 MYH9 CENPF VPS33A TSG101 HNRNPH1 HNRNPH2 RPL10A CYFIP1 PPP3CA DST SRGAP3 TLN2 PPP1R9B AKT1 HSPA1L DYNC1H1 | 6.54e-06 | 716 | 150 | 18 | int:SNCA |
| Interaction | GRB2 interactions | MYH9 PIK3R3 TSG101 HUNK ITGA4 BCR HNRNPH1 MAP3K1 DOCK5 ASAP2 PPP3CA MAPK12 RACGAP1 FTL FGFR1 FGFR3 FGFR2 HSPA1L DYNC1H1 | 8.90e-06 | 806 | 150 | 19 | int:GRB2 |
| Interaction | FGF6 interactions | 1.38e-05 | 7 | 150 | 3 | int:FGF6 | |
| Interaction | FGF18 interactions | 1.38e-05 | 7 | 150 | 3 | int:FGF18 | |
| Interaction | FBXO43 interactions | 1.88e-05 | 74 | 150 | 6 | int:FBXO43 | |
| Interaction | C11orf52 interactions | ABCC1 PPFIA1 PSD3 ADCY9 CNNM4 CYFIP1 DST TIAM1 AKT2 MARK2 ATP1A1 | 2.20e-05 | 311 | 150 | 11 | int:C11orf52 |
| Interaction | FGF5 interactions | 2.20e-05 | 8 | 150 | 3 | int:FGF5 | |
| Interaction | FGF23 interactions | 2.20e-05 | 8 | 150 | 3 | int:FGF23 | |
| Interaction | EPHA2 interactions | ABCC1 PPFIA1 PIK3R3 PSD3 PARD3B TSG101 ITGA4 ADCY9 CYFIP1 DST TIAM1 AKT1 FGFR1 FGFR3 FGFR2 MARK2 ATP1A1 | 2.63e-05 | 719 | 150 | 17 | int:EPHA2 |
| Interaction | CACNA1D interactions | 2.79e-05 | 24 | 150 | 4 | int:CACNA1D | |
| Interaction | AGAP2 interactions | 2.85e-05 | 210 | 150 | 9 | int:AGAP2 | |
| Interaction | MARK4 interactions | 3.62e-05 | 83 | 150 | 6 | int:MARK4 | |
| Interaction | MCAM interactions | PPFIA1 PSD3 GJC1 PARD3B ITGA4 ADCY9 CNNM4 CYFIP1 DST TIAM1 MARK2 ATP1A1 HSPA1L | 4.94e-05 | 468 | 150 | 13 | int:MCAM |
| Interaction | TERF2 interactions | EEFSEC MYH9 CENPF SYNE1 PIK3R3 SMC6 HNRNPH1 RYR2 CYFIP1 DST NFRKB | 4.96e-05 | 340 | 150 | 11 | int:TERF2 |
| Interaction | STUB1 interactions | MYH9 IREB2 TRIM68 HUNK BCR NLRP3 RPL10A S100A2 OLFM3 PPP3CA DNAJC12 AKT1 FGFR3 DNAJA1 HSPA1L | 5.00e-05 | 608 | 150 | 15 | int:STUB1 |
| Interaction | ARHGEF39 interactions | 6.01e-05 | 56 | 150 | 5 | int:ARHGEF39 | |
| Interaction | SH3BP5 interactions | 6.95e-05 | 30 | 150 | 4 | int:SH3BP5 | |
| Interaction | KLB interactions | 8.46e-05 | 12 | 150 | 3 | int:KLB | |
| Interaction | AP2M1 interactions | MYH9 ITGA4 BCR PRPF18 TIAM1 PRKAR1B PPP1R9B FGFR1 MARK2 TNKS2 HSPA1L WNK3 | 9.29e-05 | 430 | 150 | 12 | int:AP2M1 |
| Interaction | ACTA1 interactions | MYH9 MYL1 MYO7A MAK16 HNRNPH1 S100A2 CYFIP1 DST PPP1R9B AKT1 FGFR1 | 1.08e-04 | 371 | 150 | 11 | int:ACTA1 |
| Interaction | ARF6 interactions | ABCC1 PPFIA1 PSD3 ITGA4 ADCY9 HNRNPH1 ASAP2 CYFIP1 TIAM1 RACGAP1 FGFR2 MARK2 ATP1A1 DYNC1H1 | 1.22e-04 | 584 | 150 | 14 | int:ARF6 |
| Interaction | RAC1 interactions | DOCK2 ABCC1 MYH9 PPFIA1 PSD3 ITGA4 BCR ADCY9 DOCK5 CYFIP1 DST TIAM1 SRGAP3 FAM169A RACGAP1 PPP1R9B AKT1 MARK2 ATP1A1 ATP1A3 | 1.24e-04 | 1063 | 150 | 20 | int:RAC1 |
| Interaction | FGF3 interactions | 1.32e-04 | 66 | 150 | 5 | int:FGF3 | |
| Interaction | KL interactions | 1.39e-04 | 14 | 150 | 3 | int:KL | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.29e-06 | 206 | 101 | 9 | 682 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 5.83e-06 | 7 | 101 | 3 | 1208 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 1.09e-04 | 17 | 101 | 3 | 1291 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 1.92e-04 | 95 | 101 | 5 | 59 | |
| GeneFamily | Yippee like family | 3.06e-04 | 5 | 101 | 2 | 1130 | |
| GeneFamily | ArfGAPs | 8.17e-04 | 33 | 101 | 3 | 395 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 8.46e-04 | 8 | 101 | 2 | 281 | |
| GeneFamily | Anoctamins | 1.35e-03 | 10 | 101 | 2 | 865 | |
| GeneFamily | MAGE family | 1.44e-03 | 40 | 101 | 3 | 1136 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.44e-03 | 40 | 101 | 3 | 321 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 1.64e-03 | 11 | 101 | 2 | 286 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 3.98e-03 | 17 | 101 | 2 | 684 | |
| GeneFamily | EF-hand domain containing | 7.71e-03 | 219 | 101 | 5 | 863 | |
| Coexpression | KIM_WT1_TARGETS_12HR_UP | 5.63e-06 | 166 | 151 | 8 | M15535 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 2.11e-05 | 199 | 151 | 8 | M5893 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN | 2.11e-05 | 199 | 151 | 8 | M4407 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | FAM184A MYO7A YPEL2 ANO5 GRM4 CERT1 RYR2 OLFM3 NALCN SRGAP3 FAM169A PRKAR1B DNAJC12 TLN2 EEA1 CAMTA1 ATP1A3 MUC2 WNK3 | 2.11e-05 | 1106 | 151 | 19 | M39071 |
| Coexpression | GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 2.18e-05 | 200 | 151 | 8 | M7168 | |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING | LRRC8E GNE SYNE1 PSD3 GATM GRM4 ADCY9 HNRNPH1 PPP3CA DST TIAM1 FILIP1L | 3.90e-05 | 506 | 151 | 12 | M253 |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | RANGAP1 GNE MYO7A PPFIA1 GATM REN ITGA4 BDH1 ADCY9 MAP3K1 DOCK5 DST TIAM1 SRGAP3 PPP1R9B AKT2 ATP1A1 ATP1A2 WNK3 | 1.06e-05 | 884 | 146 | 19 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000 |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SMG1 MYH9 HNRNPH1 HNRNPH2 MAP3K1 CYFIP1 DST FGFR2 ATP1A1 TNKS2 | 1.80e-09 | 198 | 153 | 10 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SMG1 MYH9 HNRNPH1 HNRNPH2 MAP3K1 CYFIP1 DST FGFR2 ATP1A1 TNKS2 | 1.80e-09 | 198 | 153 | 10 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SMG1 MYH9 HNRNPH1 HNRNPH2 MAP3K1 CYFIP1 DST FGFR2 ATP1A1 TNKS2 | 1.89e-09 | 199 | 153 | 10 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.20e-07 | 190 | 153 | 8 | 979b1476fd2692fde977ce56257315fcfc8a01d5 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-07 | 198 | 153 | 8 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.55e-07 | 199 | 153 | 8 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.55e-07 | 199 | 153 | 8 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.55e-07 | 199 | 153 | 8 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-06 | 160 | 153 | 7 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-06 | 160 | 153 | 7 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.15e-06 | 171 | 153 | 7 | 5efd15300f865ebf651e0888265cbd717bc3b9d3 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.71e-06 | 177 | 153 | 7 | 2b63f0529ef73e0eede9b7ef1f08b0a0426a9c82 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-06 | 178 | 153 | 7 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-06 | 180 | 153 | 7 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-06 | 188 | 153 | 7 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.03e-06 | 188 | 153 | 7 | a906c29e3fda22eecfec3e5cac706c417bf2b7a4 | |
| ToppCell | COPD-Lymphoid-NK|World / Disease state, Lineage and Cell class | 4.17e-06 | 189 | 153 | 7 | c0ac160fa7e68b92414fb1600abcac8ad1a42232 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.32e-06 | 190 | 153 | 7 | 951e067d14412db67dc3babcdf61e41717d7b429 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.47e-06 | 191 | 153 | 7 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.63e-06 | 192 | 153 | 7 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.63e-06 | 192 | 153 | 7 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | Thalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.79e-06 | 193 | 153 | 7 | 712a4acd1167e43543950bc819ff11984e6f718d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.95e-06 | 194 | 153 | 7 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.95e-06 | 194 | 153 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.12e-06 | 195 | 153 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.30e-06 | 196 | 153 | 7 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.48e-06 | 197 | 153 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.48e-06 | 197 | 153 | 7 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.48e-06 | 197 | 153 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | (1)_T_cell-(15)_Treg|(1)_T_cell / shred on Cell_type and subtype | 5.48e-06 | 197 | 153 | 7 | 6e7723e8b977be35c60cc11ac7cfa4f71339441e | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.48e-06 | 197 | 153 | 7 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.48e-06 | 197 | 153 | 7 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.85e-06 | 199 | 153 | 7 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.85e-06 | 199 | 153 | 7 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.85e-06 | 199 | 153 | 7 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | (10)_Ciliated|World / shred by cell type by condition | 6.05e-06 | 200 | 153 | 7 | 1b6a8025bd2746b626040058c122b1be3ab2fa61 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 6.05e-06 | 200 | 153 | 7 | 9ae434c78e08adf95da49c85616e3ca72d1227bf | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.67e-06 | 139 | 153 | 6 | 505bf5a483fc2ba69377db9850c3b26ab2f416d1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.06e-05 | 144 | 153 | 6 | 0322fef818a963be00535d5f141f028d43de5c6a | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.29e-05 | 149 | 153 | 6 | 10ffd0051fb027bbebc662ca602c80d89bbf99c6 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.67e-05 | 156 | 153 | 6 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.54e-05 | 168 | 153 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.54e-05 | 168 | 153 | 6 | 4b5be7c6662eceddf90a65015f12908278d1664e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.54e-05 | 168 | 153 | 6 | 689c41f6e9f65381570991cc311cba49a57ec955 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 169 | 153 | 6 | ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 169 | 153 | 6 | c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.00e-05 | 173 | 153 | 6 | 51328a60ffaf34fa0f7df6084d348b5efc9917f5 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.00e-05 | 173 | 153 | 6 | b77cd5dbda3a206922f20224f4e10a3bf712f7db | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-05 | 174 | 153 | 6 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.13e-05 | 105 | 153 | 5 | 9ed5482b445eacf16d5769f79438098b0e71123a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.20e-05 | 175 | 153 | 6 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 175 | 153 | 6 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-gdT|Int-URO / Disease, Lineage and Cell Type | 3.30e-05 | 176 | 153 | 6 | 15016a73c953d8d3e7c32a05ead5e7261f9914ca | |
| ToppCell | NS-critical-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.30e-05 | 176 | 153 | 6 | b794275fdd757b8fa2108e3c867f23da2649146d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 176 | 153 | 6 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-05 | 177 | 153 | 6 | e1e45956887371b1c18f1eb479dd930031497520 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.41e-05 | 177 | 153 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.63e-05 | 179 | 153 | 6 | d15182c668d7c37be8214cad9f1fe35d1409c9a1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.63e-05 | 179 | 153 | 6 | e22a275a7c0ed19113c833a75d6c49fcc19aa13a | |
| ToppCell | Striatum-Endothelial-MURAL|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.63e-05 | 179 | 153 | 6 | 3d58babf44e47462c3d4129dd2e94a2339fd7ce0 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 179 | 153 | 6 | 36ad18f52e175ab636ceaa3be81212fa362c96c1 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 179 | 153 | 6 | bfc226bcf0b93525992344f968268a261d86fcbf | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.63e-05 | 179 | 153 | 6 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.63e-05 | 179 | 153 | 6 | 99167ac678cae5c35b1d4f4a81b32000437c00c2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-05 | 180 | 153 | 6 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.86e-05 | 181 | 153 | 6 | 6aef84616e8d2faf54b7e9e6cd02f33c3066dabc | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.86e-05 | 181 | 153 | 6 | 40df0afcb6848202da54670e84f22d7c3a515d01 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.86e-05 | 181 | 153 | 6 | 2b53a65ca5616a7b9f64232c3e0b7212d1e2f063 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-05 | 181 | 153 | 6 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.86e-05 | 181 | 153 | 6 | 40d3829ae4aaf81e8616c3499ff8933137fc1cc4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-05 | 181 | 153 | 6 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 182 | 153 | 6 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 182 | 153 | 6 | 010a7364da46101cb5068891fd7bc712ea8f13bd | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 3.98e-05 | 182 | 153 | 6 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.98e-05 | 182 | 153 | 6 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-05 | 182 | 153 | 6 | f96095b81188b52db8fcfca4837129cfcd9bd7b7 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 182 | 153 | 6 | b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01 | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 4.10e-05 | 183 | 153 | 6 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.23e-05 | 184 | 153 | 6 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.23e-05 | 184 | 153 | 6 | 23c24ab5786af33d605bc445d06117b9da6c6331 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.23e-05 | 184 | 153 | 6 | 797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.23e-05 | 184 | 153 | 6 | 77d5b60a20b277f589b18f7a131142a7ef2dac17 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.23e-05 | 184 | 153 | 6 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-05 | 185 | 153 | 6 | cdd75abdaa1ecedfd2e636203b83a6ac1782f0c3 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.36e-05 | 185 | 153 | 6 | 87151ab95530e70d61328b336518df58db584acb | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-05 | 185 | 153 | 6 | 70de48988c1f8e0809afc8092b663aa439d8e528 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-05 | 185 | 153 | 6 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.36e-05 | 185 | 153 | 6 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class | 4.36e-05 | 185 | 153 | 6 | 9a8b8360d99375b726ca8e3c9a3f9b08919892d7 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.36e-05 | 185 | 153 | 6 | b1e84228c95be8ccf7c3c1afb66b71ffb93cf61e | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-05 | 186 | 153 | 6 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-05 | 186 | 153 | 6 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 4.63e-05 | 187 | 153 | 6 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.63e-05 | 187 | 153 | 6 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.63e-05 | 187 | 153 | 6 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-05 | 187 | 153 | 6 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 4.77e-05 | 188 | 153 | 6 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.77e-05 | 188 | 153 | 6 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.77e-05 | 188 | 153 | 6 | e7681efb4d2de7f1d8a89552fff76a829376bf1b | |
| ToppCell | COPD-Lymphoid-NK|COPD / Disease state, Lineage and Cell class | 4.77e-05 | 188 | 153 | 6 | c9a227c8e71b69929d43e9afb8306a95c8163778 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.53e-05 | 49 | 91 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea | 1.07e-06 | 4 | 148 | 3 | ctd:C568950 | |
| Drug | 22,23-dihydrobufalin | 2.67e-06 | 5 | 148 | 3 | CID000195392 | |
| Drug | thevetin A | 2.67e-06 | 5 | 148 | 3 | CID000441873 | |
| Drug | 3-acetylstrophanthin | 2.67e-06 | 5 | 148 | 3 | CID003082282 | |
| Drug | 5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one | 2.94e-06 | 16 | 148 | 4 | ctd:C561052 | |
| Drug | HDMA | 3.82e-06 | 17 | 148 | 4 | CID000131092 | |
| Drug | valinomycin | 5.23e-06 | 39 | 148 | 5 | CID000005649 | |
| Drug | Palifermin | 5.31e-06 | 6 | 148 | 3 | DB00039 | |
| Drug | ETH157 | 5.31e-06 | 6 | 148 | 3 | CID000563154 | |
| Drug | Proxyphylline [603-00-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 5.89e-06 | 197 | 148 | 9 | 5993_DN | |
| Drug | Digocin | 6.34e-06 | 70 | 148 | 6 | CID000003062 | |
| Drug | nsc25485 | ABCC1 PIK3R3 REN ADCY9 ABCB1 PKD1 SCNN1B AKT1 ATP1A1 ATP1A2 ATP1A3 | 6.49e-06 | 312 | 148 | 11 | CID000004605 |
| Drug | AC1L3C9O | 7.74e-06 | 110 | 148 | 7 | CID000002521 | |
| Drug | H2O2 | DOCK2 PIK3R3 IREB2 REN ITGA4 ADCY9 MAP3K1 RYR2 ABCB1 S100A2 DOCK5 PLA2R1 PPP3CA MAPK12 NFRKB AKT1 FTL FGFR1 ATP1A1 ATP1A2 ATP1A3 TNKS2 | 8.31e-06 | 1183 | 148 | 22 | CID000000784 |
| Drug | AC1MRHRO | 8.56e-06 | 43 | 148 | 5 | CID003468412 | |
| Drug | potassium | MYL1 SYNE1 PIK3R3 GJC1 REN GRM4 GRM8 ADCY9 RYR2 PLA2R1 CACNA2D4 SCG2 PKD1 SCNN1B AKT1 AKT2 ATP1A1 ATP1A2 ATP1A3 WNK3 | 8.76e-06 | 1008 | 148 | 20 | CID000000813 |
| Drug | dihydrodigitoxigenin | 9.24e-06 | 7 | 148 | 3 | CID000107549 | |
| Drug | AC1NST54 | 9.41e-06 | 21 | 148 | 4 | CID005315525 | |
| Drug | genistein | ABCC1 RANGAP1 MYL1 ANGPT1 PIK3R3 ITGA4 HNRNPH1 HNRNPH2 RYR2 ABCB1 CACNA2D4 DST MAPK12 PKD1 AKT1 AKT2 FGFR1 FGFR3 FGFR2 MARK2 DYNC1H1 | 1.16e-05 | 1117 | 148 | 21 | CID005280961 |
| Drug | AC1L1KMJ | MYL1 MYO7A PIK3R3 ITGA4 MAP3K1 DST MAPK12 TIAM1 PKD1 AKT1 FTL EEA1 MARK2 | 1.46e-05 | 476 | 148 | 13 | CID000030956 |
| Drug | Razoxane | 1.48e-05 | 48 | 148 | 5 | ctd:D011929 | |
| Drug | Haloperidol | ABCC1 PIK3R3 SREBF2 MAP3K1 ABCB1 PPP3CA PPP1R9B AKT1 AKT2 ATP1A1 ATP1A3 | 1.53e-05 | 342 | 148 | 11 | ctd:D006220 |
| Drug | lonafarnib | 1.70e-05 | 124 | 148 | 7 | CID000148195 | |
| Drug | nifedipine | MYH9 MYL1 IREB2 REN GRM4 GRM8 NLRP3 RYR2 ABCB1 CACNA2D4 PPP3CA PKD1 | 1.80e-05 | 415 | 148 | 12 | CID000004485 |
| Drug | tipifarnib | 2.20e-05 | 52 | 148 | 5 | ctd:C402769 | |
| Drug | amyl nitrite | 2.42e-05 | 53 | 148 | 5 | CID000008053 | |
| Drug | NSC7524 | 2.60e-05 | 182 | 148 | 8 | CID000005657 | |
| Drug | calphostin C | MYL1 PIK3R3 REN GRM4 GRM8 ADCY9 MAP3K1 ABCB1 PPP3CA MAPK12 AKT1 FGFR2 | 2.61e-05 | 431 | 148 | 12 | CID000002533 |
| Drug | 2,4-dinitrophenol | 2.71e-05 | 90 | 148 | 6 | CID000001493 | |
| Drug | orthovanadate | ABCC1 KIF6 MYO7A PIK3R3 DHDDS REN ADCY9 ABCB1 AKT1 ATP1A1 ATP1A3 DYNC1H1 | 2.86e-05 | 435 | 148 | 12 | CID000061672 |
| Drug | NSC89595 | 3.46e-05 | 57 | 148 | 5 | CID000002464 | |
| Drug | baclofen | 3.67e-05 | 191 | 148 | 8 | CID000002284 | |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; PC3; HT_HG-U133A | 3.95e-05 | 193 | 148 | 8 | 1817_UP | |
| Drug | SU4984 | 4.20e-05 | 2 | 148 | 2 | DB02058 | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A | 4.25e-05 | 195 | 148 | 8 | 5004_DN | |
| Drug | dithiane | 4.27e-05 | 11 | 148 | 3 | CID000136335 | |
| Drug | ouabagenin | 4.27e-05 | 11 | 148 | 3 | CID000010497 | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 4.40e-05 | 196 | 148 | 8 | 6058_DN | |
| Drug | staurosporine; Down 200; 0.01uM; MCF7; HG-U133A | 4.40e-05 | 196 | 148 | 8 | 425_DN | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; PC3; HT_HG-U133A | 4.57e-05 | 197 | 148 | 8 | 6360_DN | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; HL60; HT_HG-U133A | 5.08e-05 | 200 | 148 | 8 | 2434_UP | |
| Drug | BAPTA | 5.34e-05 | 324 | 148 | 10 | CID000104751 | |
| Drug | AC1L1KC5 | PIK3R3 REN GRM4 GRM8 ADCY9 RYR2 S100A2 CACNA2D4 PPP3CA MAPK12 PKD1 AKT1 MARK2 | 5.48e-05 | 541 | 148 | 13 | CID000005428 |
| Drug | PD 166285 | 5.67e-05 | 12 | 148 | 3 | CID005311382 | |
| Drug | aldosterone | REN RYR2 ABCB1 CACNA2D4 PPP3CA PKD1 SCNN1B AKT2 ATP1A1 ATP1A2 ATP1A3 | 5.97e-05 | 397 | 148 | 11 | CID000005839 |
| Drug | mitoxantrone | 6.81e-05 | 154 | 148 | 7 | CID000004212 | |
| Drug | AC1L1KS5 | PIK3R3 GRM4 GRM8 ADCY9 RYR2 CACNA2D4 MAPK12 TIAM1 PKD1 MARK2 | 6.88e-05 | 334 | 148 | 10 | CID000005631 |
| Drug | Fluorouracil | ABCC1 ANGPT1 ACADL GNE GJC1 IREB2 BDH1 PRPF18 ADCY9 HNRNPH1 ABCB1 RPL10A S100A2 PPP3CA DST SCG2 SCNN1B AKT1 AKT2 FGFR2 FZD2 FILIP1L | 7.22e-05 | 1364 | 148 | 22 | ctd:D005472 |
| Drug | A-32686 | 7.34e-05 | 13 | 148 | 3 | CID000004951 | |
| Drug | 12 p | 7.93e-05 | 274 | 148 | 9 | CID000081248 | |
| Drug | ponatinib | 8.13e-05 | 68 | 148 | 5 | ctd:C545373 | |
| Drug | verapamil | ABCC1 MYH9 REN ADCY9 RYR2 ABCB1 CACNA2D4 PKD1 SCNN1B ATP1A1 ATP1A2 ATP1A3 | 8.94e-05 | 490 | 148 | 12 | CID000002520 |
| Drug | SU6668 | 9.34e-05 | 70 | 148 | 5 | CID000206042 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | ABCC1 MYL1 REN ADCY9 RYR2 CACNA2D4 MAPK12 SCG2 PKD1 AKT1 ATP1A2 ATP1A3 FZD2 | 1.05e-04 | 577 | 148 | 13 | CID000000295 |
| Drug | forskolin from Coleus forskohlii | MYL1 PIK3R3 REN GRM4 GRM8 ADCY9 RYR2 ABCB1 RPL10A CACNA2D4 MAPK12 SCG2 SCNN1B AKT1 FGFR1 FGFR3 FGFR2 MARK2 | 1.06e-04 | 1013 | 148 | 18 | CID000003413 |
| Drug | isethionate | 1.07e-04 | 38 | 148 | 4 | CID000007866 | |
| Drug | NSC-84513 | 1.16e-04 | 15 | 148 | 3 | CID000256927 | |
| Drug | chelerythrine | MYL1 PIK3R3 GRM4 GRM8 ADCY9 CACNA2D4 PPP3CA MAPK12 AKT1 MARK2 | 1.19e-04 | 357 | 148 | 10 | CID000002703 |
| Drug | gabapentin | 1.22e-04 | 169 | 148 | 7 | CID000003446 | |
| Drug | B-08 | 1.25e-04 | 3 | 148 | 2 | CID016086421 | |
| Drug | tripeptide tyroservatide | 1.25e-04 | 3 | 148 | 2 | ctd:C510683 | |
| Drug | Technetium Tc 99m Sestamibi | 1.25e-04 | 3 | 148 | 2 | ctd:D017256 | |
| Drug | taxane | 1.25e-04 | 3 | 148 | 2 | ctd:C080625 | |
| Drug | 1-amino-2-phosphonomethylcyclopropanecarboxylic acid | 1.25e-04 | 3 | 148 | 2 | ctd:C523415 | |
| Drug | amorphigenin | 1.25e-04 | 3 | 148 | 2 | CID000092207 | |
| Drug | nilvadipine | 1.25e-04 | 3 | 148 | 2 | ctd:C035100 | |
| Drug | gomisin | 1.25e-04 | 3 | 148 | 2 | CID005317796 | |
| Drug | robinin | 1.25e-04 | 3 | 148 | 2 | CID005281693 | |
| Drug | estrone benzoate | 1.25e-04 | 3 | 148 | 2 | ctd:C024552 | |
| Drug | Ouabain | 1.29e-04 | 119 | 148 | 6 | ctd:D010042 | |
| Drug | BDP_X | 1.31e-04 | 40 | 148 | 4 | CID000978607 | |
| Drug | AC1L1JYL | DOCK2 ABCC1 MYL1 ANGPT1 PIK3R3 ABCB1 ASAP2 MAPK12 TIAM1 AKT1 MARK2 | 1.31e-04 | 434 | 148 | 11 | CID000005262 |
| Drug | BAPTA-AM | 1.32e-04 | 293 | 148 | 9 | CID000002293 | |
| Drug | arabinosyladenine | ABCC1 MYL1 PIK3R3 REN GRM4 GRM8 ADCY9 RYR2 ABCB1 CACNA2D4 MAPK12 PKD1 ATP1A1 ATP1A2 ATP1A3 | 1.37e-04 | 762 | 148 | 15 | CID000000191 |
| Drug | NVP & EFV | 1.42e-04 | 121 | 148 | 6 | CID000492400 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 1.66e-04 | 79 | 148 | 5 | CID005287890 | |
| Drug | Aldosterone | 1.66e-04 | 79 | 148 | 5 | ctd:D000450 | |
| Drug | carbonyl cyanide m-chlorophenylhydrazone | 1.69e-04 | 125 | 148 | 6 | CID000002603 | |
| Drug | trimethaphan | 1.87e-04 | 81 | 148 | 5 | CID000023576 | |
| Drug | vanadyl | 1.87e-04 | 307 | 148 | 9 | CID000061671 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | 1.91e-04 | 308 | 148 | 9 | CID000001915 | |
| Drug | AC1L1F3Q | 2.04e-04 | 18 | 148 | 3 | CID000003068 | |
| Drug | acetylstrophanthidin | 2.04e-04 | 18 | 148 | 3 | CID000006062 | |
| Drug | NSC 234205 | 2.04e-04 | 18 | 148 | 3 | CID000010104 | |
| Drug | aluminum | 2.06e-04 | 184 | 148 | 7 | CID000104727 | |
| Drug | apigenin | 2.06e-04 | 184 | 148 | 7 | CID005280443 | |
| Drug | Lithium | 2.13e-04 | 246 | 148 | 8 | ctd:D008094 | |
| Drug | Digoxin | 2.26e-04 | 46 | 148 | 4 | ctd:D004077 | |
| Drug | FTI 277 | 2.42e-04 | 19 | 148 | 3 | ctd:C096856 | |
| Drug | Akti-1/2 | 2.42e-04 | 19 | 148 | 3 | CID010196499 | |
| Drug | taxinine K | 2.50e-04 | 4 | 148 | 2 | CID005321708 | |
| Drug | fluorexon | 2.50e-04 | 4 | 148 | 2 | ctd:C007740 | |
| Drug | 8-azidoadenosine 5'-triphosphate | 2.50e-04 | 4 | 148 | 2 | ctd:C017040 | |
| Drug | Gsh-pga1 | 2.50e-04 | 4 | 148 | 2 | CID005281911 | |
| Drug | emamectin | 2.50e-04 | 4 | 148 | 2 | ctd:C443359 | |
| Drug | 1-cyclohexyl-4-(3-(5-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl)-piperazine | 2.50e-04 | 4 | 148 | 2 | ctd:C505382 | |
| Drug | AS701 | 2.50e-04 | 4 | 148 | 2 | CID000133528 | |
| Drug | sulfinosine | 2.50e-04 | 4 | 148 | 2 | CID000130209 | |
| Drug | Rauwolscine hydrochloride [6211-32-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.51e-04 | 190 | 148 | 7 | 6274_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.51e-04 | 190 | 148 | 7 | 6979_UP | |
| Disease | TWIST1-related craniosynostosis | 4.93e-07 | 4 | 148 | 3 | cv:C4551902 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.64e-07 | 195 | 148 | 9 | DOID:1574 (implicated_via_orthology) | |
| Disease | bone disease (implicated_via_orthology) | 1.23e-06 | 5 | 148 | 3 | DOID:0080001 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | ABCC1 KIF6 MYH9 CENPF ZNF366 SYNE1 SMC6 SREBF2 UBLCP1 MAP3K1 ABCB1 CNNM4 SRGAP3 DAW1 SCNN1B AKT1 AKT2 FGFR1 FGFR2 | 1.95e-06 | 1074 | 148 | 19 | C0006142 |
| Disease | Mammary Carcinoma, Human | ABCC1 MYH9 CENPF ZNF366 SYNE1 SREBF2 UBLCP1 MAP3K1 ABCB1 AKT1 AKT2 FGFR1 FGFR2 | 2.65e-06 | 525 | 148 | 13 | C4704874 |
| Disease | Mammary Neoplasms, Human | ABCC1 MYH9 CENPF ZNF366 SYNE1 SREBF2 UBLCP1 MAP3K1 ABCB1 AKT1 AKT2 FGFR1 FGFR2 | 2.65e-06 | 525 | 148 | 13 | C1257931 |
| Disease | high grade glioma (implicated_via_orthology) | 2.75e-06 | 44 | 148 | 5 | DOID:3070 (implicated_via_orthology) | |
| Disease | Mammary Neoplasms | ABCC1 MYH9 CENPF ZNF366 SYNE1 SREBF2 UBLCP1 MAP3K1 ABCB1 AKT1 AKT2 FGFR1 FGFR2 | 2.77e-06 | 527 | 148 | 13 | C1458155 |
| Disease | Breast Carcinoma | ABCC1 MYH9 CENPF ZNF366 SYNE1 SREBF2 UBLCP1 MAP3K1 ABCB1 AKT1 AKT2 FGFR1 FGFR2 | 3.46e-06 | 538 | 148 | 13 | C0678222 |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 4.26e-06 | 7 | 148 | 3 | DOID:0060178 (implicated_via_orthology) | |
| Disease | Craniosynostosis syndrome | 4.26e-06 | 7 | 148 | 3 | cv:C0010278 | |
| Disease | Schizophrenia | CNNM2 ZSCAN31 SREBF2 PSD3 GRM4 GRM8 ABCB1 CYFIP1 SRGAP3 PPP1R9B AKT1 FGFR1 FGFR2 MARK2 HSPA1L WNK3 | 9.94e-06 | 883 | 148 | 16 | C0036341 |
| Disease | JACKSON-WEISS SYNDROME | 2.50e-05 | 2 | 148 | 2 | C0795998 | |
| Disease | ALTERNATING HEMIPLEGIA OF CHILDHOOD 1 | 2.50e-05 | 2 | 148 | 2 | C3549447 | |
| Disease | FGFR2-related craniosynostosis | 2.50e-05 | 2 | 148 | 2 | cv:CN231480 | |
| Disease | PFEIFFER SYNDROME | 2.50e-05 | 2 | 148 | 2 | 101600 | |
| Disease | Cutis Gyrata Syndrome of Beare And Stevenson | 2.50e-05 | 2 | 148 | 2 | C1852406 | |
| Disease | Pfeiffer type acrocephalosyndactyly | 2.50e-05 | 2 | 148 | 2 | C2931888 | |
| Disease | Isolated coronal synostosis | 2.50e-05 | 2 | 148 | 2 | cv:CN043619 | |
| Disease | Jackson-Weiss syndrome | 2.50e-05 | 2 | 148 | 2 | cv:C0795998 | |
| Disease | Jackson-Weiss syndrome (is_implicated_in) | 2.50e-05 | 2 | 148 | 2 | DOID:0111337 (is_implicated_in) | |
| Disease | alternating hemiplegia of childhood (is_implicated_in) | 2.50e-05 | 2 | 148 | 2 | DOID:0050635 (is_implicated_in) | |
| Disease | Pfeiffer syndrome | 2.50e-05 | 2 | 148 | 2 | cv:C0220658 | |
| Disease | JACKSON-WEISS SYNDROME | 2.50e-05 | 2 | 148 | 2 | 123150 | |
| Disease | Pfeiffer syndrome (is_implicated_in) | 2.50e-05 | 2 | 148 | 2 | DOID:14705 (is_implicated_in) | |
| Disease | Pfeiffer syndrome (implicated_via_orthology) | 2.50e-05 | 2 | 148 | 2 | DOID:14705 (implicated_via_orthology) | |
| Disease | nervous system disease (implicated_via_orthology) | 2.63e-05 | 12 | 148 | 3 | DOID:863 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | SYNE1 REN GRM4 BCR AKT1 AKT2 FGFR1 FGFR2 ATP1A1 ATP1A2 ATP1A3 | 3.08e-05 | 477 | 148 | 11 | C0005586 |
| Disease | cortical surface area measurement | ANO2 KIF6 CNNM2 ANGPT1 PPFIA1 PARD3B BCR CERT1 PRPF18 HNRNPH1 MAP3K1 CEP120 PKD1 TLN2 PPP1R9B FGFR1 FGFR3 FGFR2 PDZD2 | 4.58e-05 | 1345 | 148 | 19 | EFO_0010736 |
| Disease | forced expiratory volume | EEFSEC ZSCAN31 SYNE1 PSD3 IREB2 DHDDS PARD3B STK31 MAP3K1 RYR2 DST CEP120 FGFR2 PMFBP1 | 4.60e-05 | 789 | 148 | 14 | EFO_0004314 |
| Disease | Lacrimoauriculodentodigital syndrome | 7.47e-05 | 3 | 148 | 2 | C0265269 | |
| Disease | Craniofacial dysostosis type 1 | 7.47e-05 | 3 | 148 | 2 | C2931196 | |
| Disease | Levy-Hollister syndrome | 7.47e-05 | 3 | 148 | 2 | cv:C0265269 | |
| Disease | acrocephalosyndactylia (is_implicated_in) | 7.47e-05 | 3 | 148 | 2 | DOID:12960 (is_implicated_in) | |
| Disease | Pfeiffer Syndrome | 7.47e-05 | 3 | 148 | 2 | C0220658 | |
| Disease | Saethre-Chotzen Syndrome | 7.47e-05 | 3 | 148 | 2 | C0175699 | |
| Disease | Congenital hypoplasia of radius | 7.47e-05 | 3 | 148 | 2 | C0685381 | |
| Disease | Brachycephaly | 7.99e-05 | 17 | 148 | 3 | C0221356 | |
| Disease | Non-Small Cell Lung Carcinoma | 1.41e-04 | 156 | 148 | 6 | C0007131 | |
| Disease | Endometrial adenocarcinoma | 1.49e-04 | 4 | 148 | 2 | C1153706 | |
| Disease | Alternating hemiplegia of childhood | 1.49e-04 | 4 | 148 | 2 | C0338488 | |
| Disease | Liddle Syndrome | 1.49e-04 | 4 | 148 | 2 | C0221043 | |
| Disease | kidney disease (biomarker_via_orthology) | 1.54e-04 | 21 | 148 | 3 | DOID:557 (biomarker_via_orthology) | |
| Disease | chronic myeloid leukemia (is_implicated_in) | 1.54e-04 | 21 | 148 | 3 | DOID:8552 (is_implicated_in) | |
| Disease | Small cell carcinoma of lung | 1.58e-04 | 54 | 148 | 4 | C0149925 | |
| Disease | epilepsy (implicated_via_orthology) | 1.79e-04 | 163 | 148 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Alzheimer disease, polygenic risk score | CLXN ZNF366 OR5L1 SREBF2 PSD3 DHDDS GRM8 PLA2R1 OLFM3 DST TYW1 | 1.90e-04 | 586 | 148 | 11 | EFO_0030082, MONDO_0004975 |
| Disease | fibroblast growth factor receptor 3 measurement | 2.47e-04 | 5 | 148 | 2 | EFO_0020390 | |
| Disease | serum metabolite measurement | ABCC1 MYL1 ANGPT1 ACADL PIK3R3 PSD3 GATM DHDDS PARD3B HUNK PPP3CA TLN2 TRIM49B PMFBP1 | 3.01e-04 | 945 | 148 | 14 | EFO_0005653 |
| Disease | Polydactyly | 3.17e-04 | 117 | 148 | 5 | C0152427 | |
| Disease | Hypertensive disease | 4.07e-04 | 190 | 148 | 6 | C0020538 | |
| Disease | bipolar disorder (is_implicated_in) | 4.11e-04 | 29 | 148 | 3 | DOID:3312 (is_implicated_in) | |
| Disease | suberic acid measurement | 5.16e-04 | 7 | 148 | 2 | EFO_0010534 | |
| Disease | Pilomyxoid astrocytoma | 5.16e-04 | 7 | 148 | 2 | C1519086 | |
| Disease | laurylcarnitine measurement | 5.16e-04 | 7 | 148 | 2 | EFO_0021041 | |
| Disease | Large cell carcinoma of lung | 5.51e-04 | 32 | 148 | 3 | C0345958 | |
| Disease | Squamous cell carcinoma of lung | 5.51e-04 | 32 | 148 | 3 | C0149782 | |
| Disease | sleep measurement | 6.10e-04 | 135 | 148 | 5 | EFO_0004870 | |
| Disease | Disproportionate short stature | 6.19e-04 | 77 | 148 | 4 | C0878659 | |
| Disease | schizophrenia (is_implicated_in) | 6.50e-04 | 78 | 148 | 4 | DOID:5419 (is_implicated_in) | |
| Disease | Depressive disorder | 6.64e-04 | 289 | 148 | 7 | C0011581 | |
| Disease | sporadic amyotrophic lateral sclerosis, survival time | 6.86e-04 | 8 | 148 | 2 | EFO_0000714, EFO_0001357 | |
| Disease | epilepsy (is_implicated_in) | 8.79e-04 | 9 | 148 | 2 | DOID:1826 (is_implicated_in) | |
| Disease | Hamartoma Syndrome, Multiple | 8.79e-04 | 9 | 148 | 2 | C0018553 | |
| Disease | myeloid white cell count | ZNF366 PIK3R3 DHDDS ITGA4 NLRP3 PLA2R1 OLFM3 PKD1 DNAJC12 TLN2 ATP1A1 ATP1A3 TNKS2 | 9.10e-04 | 937 | 148 | 13 | EFO_0007988 |
| Disease | Cleft upper lip | 9.90e-04 | 39 | 148 | 3 | C0008924 | |
| Disease | cerebral palsy (implicated_via_orthology) | 1.10e-03 | 10 | 148 | 2 | DOID:1969 (implicated_via_orthology) | |
| Disease | cervix carcinoma (is_implicated_in) | 1.10e-03 | 10 | 148 | 2 | DOID:2893 (is_implicated_in) | |
| Disease | Cannabis Abuse | 1.10e-03 | 10 | 148 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 1.10e-03 | 10 | 148 | 2 | C0236735 | |
| Disease | Hashish Abuse | 1.10e-03 | 10 | 148 | 2 | C0018614 | |
| Disease | Head and Neck Carcinoma | 1.10e-03 | 10 | 148 | 2 | C3887461 | |
| Disease | pneumonia (implicated_via_orthology) | 1.10e-03 | 10 | 148 | 2 | DOID:552 (implicated_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.15e-03 | 41 | 148 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.15e-03 | 41 | 148 | 3 | C0858252 | |
| Disease | unipolar depression, bipolar disorder | 1.17e-03 | 156 | 148 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | Cleft palate, isolated | 1.23e-03 | 42 | 148 | 3 | C1837218 | |
| Disease | invasive ductal carcinoma (is_implicated_in) | 1.33e-03 | 11 | 148 | 2 | DOID:3008 (is_implicated_in) | |
| Disease | nose morphology measurement | 1.41e-03 | 329 | 148 | 7 | EFO_0007843 | |
| Disease | schizophrenia (is_marker_for) | 1.41e-03 | 44 | 148 | 3 | DOID:5419 (is_marker_for) | |
| Disease | Adenocarcinoma of large intestine | 1.41e-03 | 96 | 148 | 4 | C1319315 | |
| Disease | craniosynostosis (is_implicated_in) | 1.60e-03 | 12 | 148 | 2 | DOID:2340 (is_implicated_in) | |
| Disease | hyperhomocysteinemia (biomarker_via_orthology) | 1.60e-03 | 12 | 148 | 2 | DOID:9279 (biomarker_via_orthology) | |
| Disease | N-acetylputrescine measurement | 1.60e-03 | 12 | 148 | 2 | EFO_0800127 | |
| Disease | Myeloproliferative disease | 1.60e-03 | 12 | 148 | 2 | C0027022 | |
| Disease | Psychotic Disorders | 1.70e-03 | 101 | 148 | 4 | C0033975 | |
| Disease | Mental Depression | 1.83e-03 | 254 | 148 | 6 | C0011570 | |
| Disease | Unipolar Depression | 2.01e-03 | 259 | 148 | 6 | C0041696 | |
| Disease | Fibrosis | 2.04e-03 | 50 | 148 | 3 | C0016059 | |
| Disease | Cirrhosis | 2.04e-03 | 50 | 148 | 3 | C1623038 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 2.17e-03 | 108 | 148 | 4 | DOID:684 (biomarker_via_orthology) | |
| Disease | eating disorder, bipolar disorder | 2.19e-03 | 14 | 148 | 2 | EFO_0005203, MONDO_0004985 | |
| Disease | Epilepsy | 2.25e-03 | 109 | 148 | 4 | C0014544 | |
| Disease | Squamous cell carcinoma of the head and neck | 2.28e-03 | 52 | 148 | 3 | C1168401 | |
| Disease | amino acid measurement | 2.29e-03 | 678 | 148 | 10 | EFO_0005134 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 2.40e-03 | 111 | 148 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | abdominal adipose tissue measurement | 2.41e-03 | 53 | 148 | 3 | EFO_0803316 | |
| Disease | Drug habituation | 2.73e-03 | 115 | 148 | 4 | C0013170 | |
| Disease | Drug abuse | 2.73e-03 | 115 | 148 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 2.73e-03 | 115 | 148 | 4 | C4316881 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLENLMLDKDGHIKI | 276 | P31749 | |
| IKLENLMLDKDGHIK | 276 | P31751 | |
| LGDYMKNIHKKEIDL | 296 | Q96P64 | |
| KRKDGKTTREDHMKL | 126 | Q9Y6Y1 | |
| KREKLMTIKILHDFE | 866 | Q75V66 | |
| SGKFKMLEHALRDAK | 181 | Q6P9F0 | |
| RKLHKMGLKAQDTAE | 246 | P28330 | |
| CLMKDKGHDGVKELD | 86 | Q02338 | |
| VKKGEHRQLLKDSFM | 701 | P11274 | |
| KKEKGIHRLEAMLFA | 71 | Q14833 | |
| KIHKAAVKGDAAEME | 36 | A0PJZ0 | |
| RGKKDLMLEESDKTH | 106 | Q9UKB3 | |
| HKILEMEGKHKEELD | 196 | Q15389 | |
| MEGKHKEELDTLKEE | 201 | Q15389 | |
| LKEEHEKLKLMDEPA | 951 | Q9NQ90 | |
| KILEVHIDKGMKDGQ | 206 | P31689 | |
| KREHDKLMKEVGEIK | 931 | Q96MT7 | |
| DAKEGEMALLSKHKE | 346 | Q8NB25 | |
| IKDGMEDFKRHRFDK | 131 | O94823 | |
| LGDYMKNIHKKEIDL | 296 | Q5VW22 | |
| EAHERSKKAKKMIGL | 31 | O95478 | |
| LLVHMGLLKSEDKVK | 516 | P46060 | |
| EEHVILSMFKALKDK | 676 | P48200 | |
| IVEKGNHDELMKEKG | 606 | P08183 | |
| FKKGHSLREKLAEME | 151 | Q9Y5P4 | |
| HVKEGERLDAKMKRL | 1036 | Q7L576 | |
| ELFKLLKEGHRMDKP | 711 | P21802 | |
| KHGGLREEELEKMKE | 896 | Q8TEW8 | |
| KADMLKIIIKDDESH | 136 | A2A368 | |
| KMEVLGFVAKLHKKE | 251 | Q9HAY2 | |
| EEEEKALSAKHKGKM | 256 | Q9BXY0 | |
| ELGDSDLKIMLKKHH | 251 | Q6P4R8 | |
| PKDHLKKAVAEIEEM | 116 | P50440 | |
| HLDNKKLGEMRLKEA | 111 | Q9HA64 | |
| MEEKPHILGDIKSKE | 3311 | Q03001 | |
| ETHFLDEEVKLIKKM | 131 | P02792 | |
| DEEVKLIKKMGDHLT | 136 | P02792 | |
| EKEKKEHAKLHGMIR | 161 | O43150 | |
| KKEVSMDDHKLSLDE | 36 | P05023 | |
| EVKLALKKDRETMGH | 66 | P55795 | |
| KIFMGRTELKLEDKH | 921 | Q02817 | |
| LHKDALVVIKKGMDQ | 2696 | O15018 | |
| KHDGTKTEKLERLMV | 446 | Q14332 | |
| MLEYEKHGELKTKSI | 16 | Q8N136 | |
| LHEKTHLKGMEEKEE | 391 | Q8NG66 | |
| KKKAQEALHLAGMDR | 486 | Q6ZMV9 | |
| HLTKKDLRGQLKMVD | 996 | Q13136 | |
| KALRDAKMDKAKIHD | 321 | P34931 | |
| AKMDKAKIHDIVLVG | 326 | P34931 | |
| HKMKVLEELLTEGFK | 551 | Q8N8V2 | |
| ARKKLEMDLKDLEAH | 1611 | P35579 | |
| ELRHVLATLGEKMKE | 151 | P05976 | |
| EKVKKFRMHVEEGDI | 236 | Q6NSJ5 | |
| EVKLALKKDRETMGH | 66 | P31943 | |
| LRKLSMKEREHGEKE | 166 | E9PIF3 | |
| ELKKEKGIHRLEAML | 66 | O00222 | |
| ITEAEMLKGVIKEHK | 126 | A6NCF6 | |
| HTMKLEHIAADIKKG | 116 | Q8IZU1 | |
| DKLKSRLGEIHDSKM | 261 | Q92569 | |
| HDGTKTEKLEKLMVR | 456 | O75084 | |
| AKLHSEIKEKEVGMK | 1216 | Q15075 | |
| DELKKEVAMDDHKLS | 31 | P50993 | |
| FHDLVVLKGDSKKME | 546 | Q92608 | |
| KHNLKKLMEVDGGEI | 651 | Q9H7D0 | |
| KKLHDEDLLLVEGMS | 601 | Q9Y223 | |
| SLLISHEKLEKAKEM | 2866 | P49454 | |
| LEDMKQLSKEKDAHG | 1171 | Q5T9S5 | |
| HKDKMSKDLLLGIAR | 536 | Q8N960 | |
| VEELFKLLKEGHRMD | 706 | P11362 | |
| ELEHVKMELAKYKLA | 676 | Q4L180 | |
| ILKEKGGKEYIMEHV | 201 | Q8NCQ5 | |
| EHFKLLVEELMVKGV | 356 | Q7Z3S7 | |
| IHKIAKMEHGEADKK | 96 | P36383 | |
| KMEHGEADKKAARSK | 101 | P36383 | |
| LAMKDKEKAHLEEIS | 2581 | A8TX70 | |
| MSVGIDHLALDEIKK | 81 | Q9UBQ7 | |
| GNLMHKIYEKKRLEE | 146 | P57058 | |
| LMHGECVKEEKDFLK | 176 | Q9NWK9 | |
| SIMHGKDLEVEKALK | 316 | O60503 | |
| EKGHMEEKLSLLPRK | 506 | Q9Y6X4 | |
| LVAHGRMKEKEARAK | 141 | Q7KZI7 | |
| IDEKELNILHEMKGK | 286 | P13612 | |
| DLDDLKKEVAMTEHK | 21 | P13637 | |
| SVEKKIAELEMGLLH | 181 | Q14204 | |
| KKDVDKGTRHSDMFL | 256 | Q8TBB5 | |
| PMKFLREHFEKLEKE | 46 | P31321 | |
| AHKISLELDKKIMDA | 136 | A6NNS2 | |
| EELFKLLKEGHRMDK | 701 | P22607 | |
| ELKAAHIETMAKLEK | 101 | Q3B820 | |
| FSRLMEEKEKLQKHG | 101 | Q86SQ9 | |
| SKIKHLLKDLDELME | 106 | P51168 | |
| GISDEHAEDKVKKMK | 951 | Q92736 | |
| LKAHLMKEGRLEESV | 46 | Q08209 | |
| KHFQELKEKMDELLP | 141 | Q96PB7 | |
| LAKEEARKVKRLHGM | 3656 | P98161 | |
| LEIKKQMDKLDPLAH | 401 | Q2NL67 | |
| LLAEMDKVEGHVAIK | 691 | P33527 | |
| GREMENKETLKGLHK | 161 | Q13233 | |
| DLEDVDLKKFKMHLE | 16 | Q96P20 | |
| DKHRLIMGKTDKEEI | 211 | Q9NQ35 | |
| EQLKKSKEHEKLMEG | 621 | Q8TBY8 | |
| EKLAMELAKLKHESL | 91 | Q8NEH6 | |
| ELAKLKHESLKDEKM | 96 | Q8NEH6 | |
| HEEEKHNLEMLKKKG | 191 | P0CI25 | |
| KKLFSDHKELEGLMK | 411 | P0C7P3 | |
| ALAIKIMEKIKDLFH | 601 | P0C7P3 | |
| EVLLKDMEKGHSLLK | 3751 | Q8NF91 | |
| DMEKGHSLLKSAREK | 3756 | Q8NF91 | |
| KEHMTLEKGLHLAKE | 3806 | Q8NF91 | |
| HKATEKILKMFGERA | 131 | Q9NUV9 | |
| RHKGKETAAMKADLL | 221 | Q9H3E2 | |
| DVKEALRKVMGSKIH | 296 | Q8NGL2 | |
| EKLMEALGAKKRLFD | 306 | P00797 | |
| QLGDVKHLLKAMAKD | 3421 | Q96Q15 | |
| KHLLKAMAKDEEAAL | 3426 | Q96Q15 | |
| LKEKLKETETHLEML | 856 | Q8TE76 | |
| KAEKGREHIAKRAME | 601 | P13521 | |
| KVLIIIRMDSDGEKH | 741 | Q5VXU9 | |
| IRMDSDGEKHFLIKI | 746 | Q5VXU9 | |
| RTDHELGKYKDLLMK | 46 | Q9H0H5 | |
| EKKGFICKMEADIHT | 1371 | Q13018 | |
| SLKVGEAVHKAELKM | 346 | Q8IW75 | |
| GKEKEAETHRLMEKR | 311 | Q0VFZ6 | |
| LDAMLEEFKKGKSHL | 531 | Q9H8M5 | |
| MLEEFKKGKSHLAIV | 461 | Q6P4Q7 | |
| EITLKKMDHDHDGKL | 151 | Q9HAE3 | |
| EDLKKGHQKLEEMVT | 261 | Q99816 | |
| KGHLSEKMTLDLKDE | 256 | Q9BXU1 | |
| KEGKFIIELAHMIKD | 101 | O60688 | |
| KLKHKHGLVERAMDD | 471 | P57772 | |
| HGEKLKMFCKEDVLI | 101 | Q6AZZ1 | |
| MEVAVLKKLQGKDHV | 76 | Q5TCY1 | |
| KQEILKEMEHLGDSK | 191 | Q96LW9 | |
| KKEVADLSMGDLLLH | 1256 | Q13009 | |
| IHELLFKEGVMVAKK | 11 | Q9NQ39 | |
| KSKEIGLQMHEELLK | 141 | O43295 | |
| HEEEKHNLEMLKKKG | 191 | P0CI26 | |
| ELGRKDDAKVHKMFL | 91 | Q9P253 | |
| DAKMHKSGVLRKAID | 361 | Q12772 | |
| TLKKFIKLLGEIMEH | 911 | Q96SB8 | |
| DIPHMDIEALKKLNK | 81 | P62906 | |
| LDVLVEMGHKELKEI | 901 | Q9H2K2 | |
| KEGKYIIELAHMIKD | 101 | Q96QA6 | |
| KMIKDEDVHFDLAVK | 6 | Q8N895 | |
| HEEEKHNLEMLKKKG | 191 | C9J1S8 | |
| DERKMEKLKAKLHTD | 156 | Q9Y4G6 | |
| FMKAHLNRDKDKELL | 271 | Q8WVY7 | |
| DKFKLSKGEMKELLH | 26 | P29034 | |
| SKGEMKELLHKELPS | 31 | P29034 | |
| KEHEVEKMFTLKGNR | 56 | Q96AX1 | |
| HEEEKHNLEMLKKKG | 191 | A6NDI0 | |
| KEGMEKHIKRSKHLE | 746 | Q9C0G0 | |
| DLGKIMDHVKKEKRE | 316 | Q9NV66 | |
| KQIKDLMDKDFDKLH | 71 | Q5T0J7 | |
| LGKGDDHKDMDIITK | 176 | Q99633 | |
| FLARKIHADMDGKKT | 791 | Q9NYI0 | |
| KGKGHEAEDLKMLIR | 91 | Q9BVW5 | |
| VDVEDLGKIMDHVKK | 266 | Q6NUM6 | |
| RLGAMDIDTHKKGKE | 441 | Q15061 | |
| SKKGMFTDDLHKLVD | 1641 | Q9BYP7 | |
| LGKLMKHEKLGEDRI | 116 | P53778 | |
| FKGSDHLDQLKEIMK | 226 | P53778 | |
| LEVDLDKDKLLFKHM | 1501 | Q8IZF0 | |
| IGKTKIFLKDHHDML | 721 | Q13402 | |
| DMEPEKLVHKFKELQ | 661 | Q96SB3 |